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This thesis was submitted as partial requirement for the Doctorate in Clinical Psychology at the 
University of Birmingham and consists of two volumes. 
The first volume contains the research component and consists of a literature review and an 
empirical paper.  The second volume contains five clinical practice reports (CPRs) of work 
undertaken whilst on clinical placement. 
Volume I: Research Component 
The first part of volume one is a literature review of the research on outcome effectiveness of brief 
interventions (BI) for drug use disorders (DUDs) in inpatient settings.  A comparison of the 
research into brief interventions in emergency departments and psychiatric inpatient units was 
undertaken.  The evidence for efficacy of BI’s in such settings remains unclear.   
The second part of volume one is an empirical paper exploring the feasibility and outcome of 
testing a short burst brief integrated motivational intervention with people with severe mental 
illness (SMI) and co-existing substance misuse disorders (SUDs) in inpatient psychiatric settings. 
Volume II: Clinical Practice Reports (CPRs) 
The second volume of this thesis comprises four clinical practice reports (CPRs) which were 
undertaken whilst on clinical placement and the abstract for an oral presentation of a fifth case 
study. 
The first CPR (models) undertakes a psychodynamic formulation of a client with learning 
disabilities in order to generate collaborative understanding of his difficulties and plan intervention.  
An alternative systemic formulation, incorporating family beliefs and experiences is also generated.  
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The service evaluation CPR (CPR Two) reports on a services evaluation within a learning 
disabilities service of clinicians’ subjective confidence in safeguarding adults policy in regards to 
their knowledge and skills.   
CPR three (case study) presents the case of a 13 year old boys anxiety and cognitive behavioural 
intervention undertaken with him.   
The single case design study (CPR four) presents the measurement and evaluation of  anger 
difficulties and subsequent intervention undertaken with a 52 year old woman within an acute 
inpatient setting. 
CPR five (oral presentation) presents the case of a 70 year old woman with memory difficulties.  
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 Review of the outcomes for brief Interventions in acute hospital settings for patients 


















A plethora of research has been undertaken over the last twenty years to evaluate the efficacy of 
brief interventions including many randomised controlled trials (RCTs).  However findings are 
mixed.   Despite this there is sparse research on brief interventions focused on illicit drug misuse in 
inpatient settings.  This literature review sought to collate the available research and present the 
outcomes measured in two main categories of patient settings; hospital emergency departments 
(EDs) and psychiatric in-patient units.  Thirteen studies that examined the impact of a brief 
intervention in these two inpatient settings were explored.  Studies largely focused on reducing the 
levels of drug use and increasing engagement with substance treatment in both settings.  Evidence 
of the efficacy of brief interventions in positively impacting upon these outcomes was variable.  
Studies in the emergency department reported change in outcomes to a larger degree than studies 
in inpatient psychiatric settings.  When longer follow-ups were focused on findings indicated a 
lack of consensus for the evidence for the efficacy of brief interventions in these settings.   The 
review highlighted the need for further research incorporating more rigorous methodology and 









 This review will explore the evidence for brief interventions for drug use disorders in inpatient 
settings.  A brief overview on the prevalence of drug use disorders, research on brief interventions 
and the reasoning behind opportunistic intervention in inpatients settings will be given before this 
review continues on to present research studies evaluating the efficacy of brief intervention in the 
inpatient setting. 
Terminology 
For the purposes of the review the following definitions will be utilised: 
 Substance Misuse 
“The harmful use of any psychotropic substance including alcohol and either legal or illicit drugs. 
Dependence is characterised by psychological reinforcement of repeated substance-taking 
behaviour and, in some cases, a withdrawal syndrome. However, substance misuse can be harmful 
without dependence.”    
The UK National Institute for Health and Clinical Excellence (NICE, 2011) 
Drug use disorders  
“Intoxication by, dependence on, or regular, excessive consumption of psychoactive substances 
leading to social, psychological, physical or legal problems. 
(NICE, 2007)  
Co-Morbidity 
The occurrence of two or more difficulties/disorders (mental or physical).  The terms dual 




What constitutes a brief intervention can vary somewhat within substance misuse literature and 
research in the area.  The term brief intervention (B.I) can be utilised to identify interventions that 
range from feedback and education to motivational interviewing to structured therapeutic 
intervention addressing an individual’s targeted area for behaviour change.  B.I’s can range in 
frequency; between one and four sessions (Kaner et al., 2007) and duration; 5-60 minutes (Kaner et 
al., 2011).   
Emergency Department 
Units dedicated to the diagnosis and treatment of unforeseen physical health problems of an 
accidental, urgent and/or critical nature.  Also known as accident and emergency or trauma centres. 
Inpatient 











Physical and Mental Health and Co-existing Substance Misuse 
Dual diagnosis of substance misuse and a physical or mental health difficulty is a common 
occurrence in today’s society (Public Health England 2012).   The issue of substance misuse 
difficulties amongst acute hospital populations has long been an issue within physical and mental 
healthcare (Reiger et al., 1990; Kavanagh et al., 2004).   
Co-existing substance misuse presents many difficulties.  Substance misuse itself may be the 
trigger that leads to the need for hospital treatment or it may exacerbate the primary physical or 
mental health difficulty.  Effective intervention or treatment for both psychological and physical 
health difficulties may be greatly impeded by co-existing substance misuse (Sansone and Sansone, 
2008). 
It is widely acknowledged that substance misuse negatively impacts upon physical, psychological 
and social wellbeing (Crome, Chambers,Frisher, Bloor & Roberts, 2009; NICE, 2007). Research 
has found that those with mental health difficulties use substances at a higher rate than the general 
population and this use poses a greater risk in terms of symptom presentation, recovery, relapses, 
treatment compliance and mortality (Reiger et al., 1990; Kavanagh et al., 2000; Cleary, Hunt, 
Matheson & Walter, 2009).  Co-existing drug and alcohol use in those with physical health 
difficulties have also been found to impact upon treatment, recovery, symptom presentation and 
exacerbation, cost to health services and use of services and mortality (Gossop, Stewart, Treacy 
and Marsden, 2002; . 
Both brief and longer term psychological and medical interventions have been attempted to address 
and treat the misuse of substances and their impact,  with varying degrees of success (Emmen, 
Schippers, Bleijenberg & Wollersheim, 2004; Woolard, Cherpitel & Thompson, 2011, Cleary et al, 
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2009; Drake, Mueser, Brunette and McHugo, 2004; De Lima, Oliveira, Soares. Reisser and Farrell, 
2002; Kirchmayer et al, 2002; Amato et al., 2005; Ferri, Amato & Davoli, 2006).  
UK government guidelines advise that specialist mental health services offer integrated care to 
people with mental health difficulties (Department of health, 2002) and there has been an 
increasing focus on intervention in primary and secondary physical health settings (Kaner et al 
2007).  For example Nice Guidance (2007) recommends the use of psychosocial interventions, 
including brief interventions in the UK healthcare system. 
Prevalence and impact of Substance Misuse Presentations in Acute Inpatient Settings 
The 2011/2012 Crime Survey for England and Wales (Home Office, 2012) estimated that 8.9% of 
16-59 year olds had used illicit drugs in the past year, with cannabis being the most commonly 
used drug (6.9%).  Drug misuse is estimated to cost the NHS £488 million annually and drug 
related crime £13.9 billion.  Additionally drug related deaths cost £2.4 billion in 2011. When 
considering general hospital admissions, substance misuse statistics on drug misuse in England last 
year identified 6,173 general hospital admissions with a primary diagnosis of drug related mental 
health and behavioural disorder and 12,344 for poisoning by drugs (The Information Centre for 
Health and Social Care, 2012).  In 2011 there were 1605 drug related deaths in England and Wales 
(The Information Centre for Health and Social Care, 2012).   
By comparison rates of alcohol use, according to the National Office of Statistics (NOS), are over 
and above recommended units for 24 % of adults in England (Statistics on Alcohol for England, 
2010).  Of these Hazardous drinkers 4% were further classified as harmful drinkers and another 6% 
as dependant drinkers. Alcohol misuse is thought to cost the UK National Health Service £2.7 
billion a year and the UK 12.6 billion in total when including crime, antisocial behaviour and 
employee absence  (NICE, 2010).  Cherpitel et al. (2005) reported global prevalence of alcohol 
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related injury presentation to emergency departments as 24% and the Office of National Statistics 
reported an 11% rise in alcohol related hospital admissions in the UK. 
The prevalence of substance misuse amongst people experiencing severe mental health difficulties 
is thought to be high (Kavanagh et al, 2004).  The COSMIC study (Weaver et al, 2002) found as 
many as 44% of Community Mental Health Team (CMHT) patients reported substance misuse 
difficulties. Additionally 75% of drug service users and 85% of Alcohol services users were 
identified as having a psychiatric disorder.  Historically the complexity of difficulties for 
individuals with co-existing difficulties was not adequately acknowledged and they were often 
either ineligible for referral to substance misuse or mental health services or batted between 
services leading to lack of treatment for either their substance use, mental health difficulty or both.  
This impacted upon potential treatment engagement, efficacy and success.  In the same year the 
UK department of health disseminated a Dual Diagnosis Good Practice Guide in an attempt to 
manage this problem (Department of Health, 2002). 
Whilst much has been written about the prevalence of substance misuse amongst inpatient 
populations the incidence of drug consumption within acute settings by individuals during 
admission is also an issue. Wilson and Cohen (2000) highlighted the risk of increasing alcohol and 
drug use on inpatient psychiatric unit and there are many anecdotal reports of both drug and 
alcohol use occurring in acute hospital settings.  Despite this the period after initial admission is 
thought to be an opportune time to attempt intervention. 
Windows of opportunity 
It is thought that inpatient settings are the opportune environment to attempt engagement and 
fostering of motivation amongst individuals with substance misuse difficulties (Department of 
Health 2006). In mental health between the periods of acute first admission and possible sealing 
over (a maladaptive, dismissive recovery style identified by McGlashan and Levy, 1977), it is 
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theorised that as patients psychiatric symptoms become more stable they become more reflective 
about the reasons for their admission.  This is thought to be a window of opportunity for admission. 
Similarly physical health hospital admissions are considered a window of opportunity for 
intervention, namely brief interventions (Blow et al., 2010) 
Brief Interventions: Goals and Empirical efficacy 
Brief interventions will be the focal intervention explored in this review.  The main goals of brief 
interventions for substance misuse are to increase motivation or readiness to change substance 
misuse (reduction or cessation) and to increase awareness of the risks of drug and alcohol misuse.  
This is done through assessment, offering feedback and engendering change talk (Miller and 
Rollnick, 1991).  According to the Centre for Substance Misuse Treatment (Treatment 
Improvement Protocol 34, 1999) six elements encompass brief interventions.  These elements are 
Feedback, Responsibility, Advice, Menu, Empathy and Self-efficacy (FRAMES) and were devised 
by Miller and Sanchez (1994) as part of motivational interviewing. (Miller and Rollnick, 1991). 
Screening, Brief Intervention, Referral and Treatment (SBIRT) is an initiative originating in the 
United States of America.  The concept of SBIRT was originally developed for consistent use in 
emergency care settings and was later adopted in primary care community settings.  The Substance 
Abuse and Mental Health Service (SAMSHA) developed SBIRT with the aim of utilising early 
intervention to tackle substance misuse and either prevent serious dependence or facilitate 
treatment where it already occurs.  Similarly in the UK services such as Rapid Assessment, 
Interface and Discharge (RAID) have been created to cope with the demand of increasing numbers 
of people with both substance misuse and mental health difficulties presenting to the emergency 
departments of hospitals. RAID has been found to be cost effective, and reduce both length of stay 
and readmission rates (Parsonage and Fossey, 2011). 
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A plethora of research has been undertaken over the last twenty years to evaluate the efficacy of 
brief interventions including many randomised controlled trials (RCTs).  However findings are 
mixed. Some studies have found brief interventions as efficacious as longer term interventions, 
when compared to no treatment in multiple countries (Bien, Miller and Tonigan, 1993). Brief 
interventions have been found to reduce levels of use (Gentilello et al 1999; Vasilaki, Hosier and 
Cox, 2006; Kaner et al, 2007; Kaner, 2007), injury (Gentilello et al 1999; Monti et al 1999) and 
medical costs (Fleming et al, 2000; Gentillelo et al 2005, Kraemer, 2007).  In one of the most 
recent UK systematic reviews on the effects of brief interventions for co-morbid populations 
(substance misuse with either, mental health difficulties, physical health difficulties or another 
substance misuse difficulty) Kaner, Brown and Jackson (2011) evaluated both methodological 
quality and research outcomes for 14 brief intervention trials for people experiencing co-morbid 
difficulties.  Of the three trials concerned with co-morbid physical health utilising 10-15 minutes 
brief interventions, significant improvements amongst the intervention group, compared to control 
groups at various time points of follow-up, was found. By comparison, the eight trials relating to 
substance misuse and mental health difficulties showed greater yet non-significant improvement in 
intervention groups compared with controls. This effect was then lost over longer follow-up times.  
A systematic review of brief interventions for alcohol misuse highlighted methodological 
difficulties such as study designs, analysis and interpretation, interpretations of small effect sizes, 
potential bias from self-reported outcomes and the clinical application of results (Kypros, 2007).  
Additionally it is important to note that, although RCT’S are widely used in intervention studies, 
other quantitative and qualitative methodologies offer an equally valuable contribution when 
attempting to gain both empirical evidence and a better understanding of the clinical experience.  
Whilst other study methodologies suffer greater risk of bias (e.g studies that lack a control group) 
RCTs often, conversely, suffer from weaker generalisability due to the constraining nature of  the 
methodology.   It is argued that other methods offer comparatively greater ecological validity than 
RCTs should be afforded equivalent consideration. (Slade and Priebe, 2001).   For example 
systematic case designs make a worthy contribution to pilot studies. 
10 
 
Aims of the Present Review 
There is a sparsity of research on brief interventions for drug misuse in inpatient settings for drug 
use disorders.  This literature review will focus on the available research.  Based on the 
information presented, one could argue that similar to the response to substance misuse in criminal 
justice settings and community healthcare, inpatient physical and mental health settings also need 
to address substance misuse difficulties with individuals who, often repeatedly, access these 
settings (National Treatment Agency, 2009, NICE, 2007).  To date most research into the 
effectiveness of brief interventions for substance misuse in hospital settings has focused 
predominantly on alcohol misuse and research on efficacy with illicit drug use has been nearly 
exclusively in community settings.  There has been little research on the impact of brief 
interventions for drug misuse in acute in-patient settings. For example whilst there is much 
research in emergency medicine on brief interventions for alcohol misuse it has been argued that 
there is hardly any for brief interventions focused on drug misuse (Bogenschutz et al, 2009).  As 
already highlighted in UK and worldwide policy and prevalence data (e.g. Nice Clinical Guidance, 
2007; 2011; SAMSHA, 2009, Nice, 2009), there is a need for evidence based interventions and the 
evidence for what works with the aforementioned population in the inpatient setting is lacking. 
Researchers have identified the need for evaluation of brief interventions compared with treatment 
as usual due to their cost effectiveness and simple implementation. (Cleary et al 2010).  There is 
clearly a continued need to find interventions that have clinically targeted efficacious outcomes, 
are cost effective and reduce demand on services. In other areas brief interventions have been 
found to do this (Kaner et al, 2007) 
Therefore the present review will attempt to collate the available research literature on brief 
interventions for illicit drug use in acute hospital settings.  The review will focus on studies 
undertaken in this area that centre on the effectiveness of brief interventions on identified outcomes. 
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The review will be broadly organised in two main categories of acute inpatient settings that include 
(i) hospital emergency departments and (ii) psychiatric units.  Studies for each category will be 
reviewed and discussed in turn. 
In summary the aims of this systematic review are to 
1) Explore and summarise the available research evidence for brief interventions for drug 
misuse undertaken wholly or partially  in acute in-patient settings 
2) Assess the quality of the studies presented. 
3) Consider the findings of the combined two areas for comparison. 















The following terms were searched on Psych Info, Embase and Medline (1998 to April 2013): 
A. Keyword search 
I.  “Brief intervention” or “Brief therapy” or “Motivational intervention” or 
“Motivational interviewing” (all terms exploded) 
 
II. “Drug misuse” or “Drug use” or “Drug abuse” or “Substance misuse” or 
“Substance abuse” or Addiction” or “Drug dependence” (all terms exploded) 
 
III. “Psychiatric Hospital” or “Psychiatric unit” or “Mental health” or “Mental 
hospital” or “Severe mental health” or “Inpatient” or “Hospitals” or “Accident 
and emergency” or “Emergency department” or (all terms exploded) 
B. Combine I, II and III 
Initial exclusion was based on the removal of duplications, non-peer reviewed articles, a title sift 
and finally an abstract sift.  This left 33 remaining journal articles. A reference sift of these papers 
identified an additional 4 papers that met inclusion criteria.  Further examination, with the 




Inclusion and Exclusion Criteria 
Articles were included if: 
1. They included interventions that met the definition of a brief intervention  
2. The intervention focused on the participants illicit drug use (or poly alcohol and illicit drug 
use) 
3. The research setting was an emergency department or in-patient psychiatric unit.  
4. They examined the efficacy of the brief intervention. 
Articles were excluded if they were: 
1. Not English language 
2. Not peer reviewed 
3. Not about a brief intervention for patients or viewing literature on the subject  
4. Not undertaken in the aforementioned settings. 
5. Book reviews, commentaries and letters 
6. Interventions that included 6 or more sessions 
7. Sessions longer than 60 minutes in duration 
The Cochrane Handbook (Higgins and Green, 2008) was consulted when considering items to 
think about when including articles. Articles concerned with evaluating brief interventions for drug 
misuse in either an emergency department (ED) or psychiatric inpatient setting were included.  
Although brief interventions for alcohol only were excluded, interventions for both drugs and 
alcohol, also known as alcohol and other drugs (AOD) were included.  Similarly brief interventions 
in multiple settings, of which one was an ED or inpatient psychiatric settings were included. 
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Search Results and Analysis 
An additional reference sift of the papers found through the search elicited four pertinent papers 
that also met the inclusion criteria. Thirteen of the remaining papers met the inclusion criteria.  
Please see page 15 for a diagram of the process (figure 1). 
A number of quality frameworks were accessed when considering the systematic methodological 
review of the studies (e.g. Downs and Black, 1998, CASP, Cochrane handbook, 2006).  Guidance 
from the Cochrane Collaboration handbook (Higgins and Green, 2006) was the primary source for 
quality assessing all of the studies.  
Randomised Control Trials (RCTs) have been identified as the gold standard of research (Sackett 
et al, 1996; Moher, Jones and Lepage, 2001), due to having the highest methodological standards 
and rigour (i.e. high internal validity).  It is for this reason that evidence from RCT’S are used to 
indicate the strongest empirical evidence in guidance for clinical practice (e.g. NICE guidance). In 
reality all RCT’S are not created equal.  Issues such as allocation bias afflict RCT studies.  Despite 
most of the research studies in the present review being RCTs it is for such reasons that a quality 
review of the RCTs in this study are of equal importance to that of any of the other types of studies 















408 articles identified through 
aforementoned databases 
(after removing 89 duplicates) 
between 1998 – 2013. 
Reviews , editorials and 
conference abstracts were 
excluded. 
62 articles not peer reviewed. 
346 articles remaining. 
303 articles excluded based 
on the title. 
43 articles remaining. 
10 articles excluded based on 
the abstract . 
33 articles remaining. 
4 additional articles retrieved 
through hand sifting the 
articles above 
13 articles meeting the 
inclusion criteria 
Excluded based on e.g. 
- Intervention outcome focus 
on topics other than 




-In primary care settings. 
-In other hospital setting. 
-Prevalence or Incidence 
study. 
-Staff attitudes or training.  
- Family intervention. 





The GRADE approach identified in the Cochrane Handbook (Higgins and Green, 2006) denotes a 
four level hierarchy of quality.  Although RCT’s are identified as the highest quality of evidence 
this ranking can be reduced or downgraded dependant on the presence of factors such as risk of 
bias, study limitations and imprecise methodology.  The higher the level and number of factors the 
greater the downgrade (i.e. single, double or triple downgraded RCT).  Table one below depicts the 
GRADE approach and table two incorporates the studies in this review with the approach. 
Table 1: Levels of quality of a body of evidence in the GRADE approach (Taken from the 
Cochrane Collaboration Handbook, Higgins and Green, 2006) 
Underlying methodology Quality rating 
Randomized trials; or double-upgraded observational studies. High 
Downgraded randomized trials; or upgraded observational studies. Moderate 
Double-downgraded randomized trials; or observational studies. Low 
Triple-downgraded randomized trials; or downgraded observational studies; or 
case series/case reports. 
Very low 
  
Table 2: Quality rating of studies reviewed  
Quality 
rating 
Study type Emergency department Psychiatric 
1-High Randomised controlled trial 
(RCT) 
Tait et al., 2004 & 2005 
Bernstein et al., 2009  
Woolard et al., 2013 
Baker et al., 2002 
Kavanagh et al., 2004 
Martino et al., 2006 
2-Moderate Case control trial  
(CCT), Downgraded RCT 
Krupski et al., 2010 
Magill et al., 2009 
Blow et al., 2010 
 
Goti et al., 2010 
Swanson et al., 1999 
 
3-Low Controlled before and after 
(CBA) 
  
 4-Very low Interrupted time series  
(ITS), Evaluations 
D’Onfrio and Degustis, 2010 






The following section reports the outcomes of these remaining studies and two tables are presented. 
The first table (table 3) on page 19 provides a brief overview of the outcomes for brief 
interventions for drug misuse in emergency departments (EDs) and the second table (table 4) for 
brief interventions in psychiatric inpatient settings (page 29).  The section utilises the Cochrane 
reviews framework to examine the methodological quality of the included studies.  Quality criteria 
in Tables  three and four included the examination of study design, sample size, the similarity of 
measurements at baseline and outcome, the homogeneity of condition group characteristics and if 
studies were protected from sample contamination.  Quality criteria also included the exploration 
of possible bias concerned with selection (i.e. random allocation generation and allocation 
concealment), performance (i.e. blinding of participants and researchers), detection (blinding of 
outcome assessments), attrition (i.e. reporting of participant losses, exclusions and completeness of 
outcome analysis) and reporting (i.e. selective reporting of data). The final column on tables three 
and four include a column noting risk of bias with a accompanying key at the bottom of each table.  
As use of quality scores have been deemed to be fairly problematic (Centre for Review and 
Dissemination’s guidance, 2009), after consideration, it was decided that they would not be utilised 
for this review.  The Centre for Review and Dissemination’s guidance (2009) note that it is 
preferable to indicate quality in the synthesis of findings.  The section subsequent to this then 
compares the research in both areas.    The concluding section of this review provides a general 








Outcomes for Brief Interventions for Drug use in Inpatient Settings 
Research in both ED and inpatient psychiatric settings have explored the feasibility of undertaking 
brief interventions in such environments (Madras et al., 2009; Kaner et al 2011).  Evidence for the 
efficacy of BIs in each setting will be presented each in turn by outcome. 
Outcomes for brief interventions in Emergency department settings 
Eight of the thirteen studies reported in this review were undertaken in ED settings.  The type of 
physical health difficulties participants presented to the ED were reported in only two of the eight 
studies. Two of the eight studies included participants who were using illicit drugs only whilst 4 
studies included those using illicit drugs and alcohol and  2 studies using cannabis and alcohol only. 
Six of the 8 studies were RCTs, one a secondary analysis and one was a prospective observational 
study. 
Please see page 19 for a summary table (table 3) of the research on brief interventions in EDs.  The 
table includes setting, study type, follow-up length, measurement and outcome. 
1. Levels  of drug and alcohol use (reduction and abstinence) 
Most of the studies exploring the impact of brief interventions in the ED had modification of levels 
of use as a main outcome measure of efficacy.  Five of these were RCTs (Magill et al, 2009; Tait et 
al, 2004, 2005a and 2005b; Bernstein et al, 2009; Woolard et al, 2013; Blow et al, 2010) and one 
was a secondary analysis study (Madras et a, 2009).  Reductions in levels of drug use were 
measured at different follow-up time points amongst the studies. The longest follow-up for 
outcomes of effective reduction in use was up to 12 months (Magill et al, 2009; Tait et al, 2004, 
2005a and 2005b; Bernstein et al, 2009; Woolard et al, 2013). The RCTs measuring the impact of 
BI’s on poly cannabis and alcohol use (Woolard et al., 2013 and Magill et al., 2009) found 
significantly greater reductions in cannabis and alcohol use in the intervention group at 12 months.  
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Table 3: Summary table of brief interventions for drug misuse in emergency departments   
 
Author, 















Measures Outcomes  
 
Quality 





















BI  (plus consistent 
support person)  


















4 months post 
intervention=Significantly 
greater number  of the BI 
group had attended 
treatment than the TAU 
group 
Regardless to attendance at 
drug use intervention the BI 
group had more improved 
scores on the GHQ-12 than 
the TAU group. (p=<0.05) 
Across groups a greater 
proportion of those who 
attended treatment moved to 
"safer" drug use behaviour 
(non-hazardous alcohol 
consumption and/or non-
injecting drug use (IDU) 
Across groups a greater 
decline on a composite total 
drug use score 
Limited success in 
engagement with SU 
treatment BUT can 
significantly reduce ED 
presentations. 
AA= Y  AC= Y 
BO= Y  BC= Y 
IA=  Y  KP= Y 
PC= Y  SR= Y 

































+ Screen (Use in past 













9.6/3.7%  Referral to 
specialist treatment-
Criteria for Addiction 
 
(1x varied duration 







of drug and alcohol 







Drug use 67.7% lower 
(p<0.01) in BI group. 
 
Heavy alcohol use 38.6% 
lower (p<0.01) 
 
Self reported improvements 
in general health, housing, 
criminal behavior, 
employment and mental 
health. (p<0.01) from BT 
group. 
 
Feasible to screen for drug 
use along with alcohol use 
AA, AC, BO,    
BC, KP, PC,   
SR, OB, IT= 
Not applicable  
 
IA= Y   
SR=  U 
















M.I  (1x30-45 
minutes plus 20-30 
minute telephone 







feedback (with 5-10 
minute booster 





report posted to both 
3, 6 and 12 
months 














Problem Index (risk) 
No difference at baseline 
between cannabis and non-
cannabis users on readiness 
to change or self-efficacy. 
 
Current cannabis users 
found to be younger, ‘more 
likely to be white’, use more 
alcohol, other illicit drug use 




Baseline- 6 months: 
Cannabis use not a 
moderator for BI group 
response. 
 
AA= U AC=U 
BO= Y BC=N 
IA= U  KP=U 
PC= U SR=Y 






groups at 3 months.) 6 Months-12 months: Cont’d 
reductions in cannabis use 
for MI group only. 
 
Reduction in number of days 
poly cannabis use with 
alcohol ‘appeared’ to be 
function of reduced alcohol 
consumption. 
 
Young poly users generally 
at a higher risk but 
responded to BI and reduced 


























  day 
telephone booster 
 











Youth and young 
adult health and 







No significant changes or 
differences at 3 month 
follow-up. 
 
Significant increase in 
abstinence in BI group 
compared to AC group at 12 
months. 
 
No evidence for assessment 
reactivity- No difference 
between AC group and NAC 
group at 12 months. 
AA= Y  AC=Y 
BO= Y BC= Y 
IA= U   KP= Y 
PC= Y   SR=U 
OB= N  IT= Y 
 































Enhanced usual care 










Physical and mental 
health 
 
Readiness to change 
questionnaire 
 
50% attended at least one 
session of the intervention. 
 
Only 14% of the case 
management group attended 
all 5 sessions. 
 
Only 23% of the BI group 
attended both sessions 
 
Those attending significantly 
more likely to be older, 
AA=U AC=U 
BO=Y BC=Y 
IA=U  KP=U 
 PC=Y SR=N 








and frequency -past 
30 days and last year. 
 
unmarried, in action stage of 
change, insured and 
unemployed. 
 
Demographics, Reason for 
ED visit, Health functioning. 
RTC, Self-efficacy and 
substance use= Report of 











































Pre & Post: 






54% of referrals enrolled in 
engagement with specialized 
drug treatment program  
 
 
Direct referrals 30x more 
likely to enroll than indirect 
referral. 
 
ASSERT can be fully 
integrated to the ED. 
 
Demographic factors affect 
enrollment (being white, 




AA, AC, BO,   
BC, IA, KP, PC, 
SR, OB, IT = 

































BI group significantly more 
likely to engage in substance 
misuse treatment than TAU 
group. 
 
No prior engagement: The 
BI group were 1.90 times 
more likely to engage than 
the control group (95% 
CI:1.61, 2.23) 
 
AA, AC, KP, 
PC, SR, IT=  
Not applicable 
 































consequences of use 
(Risk) 
12 month FU: Significant 
difference between groups 
for decrease in days of poly 
alcohol and cannabis use: 
(M=1.25.1:95% CI=0.81–
1.54) for the Bi group Vs.  
(M=2.16:95% CI=1.56–
2.86) for the TAU group. 
And  binge drinking days: 
(M=0.72:95% CI=0.36–
1.12) for the BI group Vs.  
(M=1.77:95% 
CI=1.19–1.57) for the TAU 
group. 
 
No significant difference in 
negative consequences 
between groups. 
AA= Y  AC= Y 
BO= Y BC= Y 
IA=U KP=Y 
PC= Y SR= Y 




BI- Brief Intervention, BNI- Brief Negotiated Interview, BA= Brief advice, BT=Brief Treatment , BMI= Brief Motivational Intervention, TLFB- Time Line Follow Back, 
SBIRT- Screening Brief Intervention and Referral to Treatment, SBI- Screening and Brief Intervention, MI- Motivational Intervention, DDMI- Motivational Interviewing 
adapted for dually diagnosed psychotic and drug-related disordered patients 
Quality key:- 
AA= Allocation adequately generated, AC= Adequate allocation concealment, BO= Baseline outcome measurements similar, BC= Baseline characteristics similar, IA= 
Inadequate outcome data adequately addressed, KP= Knowledge of allocated interventions prevented, PC= Protection from contamination, SR=Free from selective reporting, 
OB=Free from other bias, IT= Intention to treat analysis      Y=Yes N=No U=Unclear
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The benefit of both longer and multiple follow-up periods in assessing the impact on levels of use 
was illustrated in the RCT by Berstein et al. (2009) with 45% of the intervention group identified 
as abstinent (by self-report and 30 day time line follow back [TLFB]) compared to 22% of the 
standard assessed control group at 12 months. However at an earlier 3 month follow-up no 
significant difference was found in abstinence between cases and controls although consumption 
levels were significantly lower and efforts to modify cannabis significantly higher for the BI group 
at the three month mark.  
In regards to frequency of drug use the studies by Tait et al. (2004, 2005a and 2005b) and Woolard 
et al. (2013) found fewer days of use following the intervention for the BI group compared with the 
TAU group. This was significant in the latter study but was a non-significant finding in the Tait 
study (Tait et al et al, 2004).   The impact on levels of use with further engagement as a treatment 
modifier was also found.  Those who attended further treatment had a greater reduction of total 
drug use compared to non-attendees in the study by Tait et al. (2004, 2005a and 2005b) regardless 
of whether they were a case or a control.  However a significantly greater number of those who 
received the BI attended substance misuse treatment.  For studies with a shorter follow-up length 
significant reductions in drug use were also found.  Madras et al. (2009) was the only study 
measuring  levels of use that was not an RCT and with a maximum follow length of six months.  
This secondary analysis of SBIRT interventions in multiple healthcare settings (the majority were 
EDs) found drug use to be 67% lower in those who undertook a BI at 6 month follow-up. 
Given the setting of these studies Bernstein et al. (2009) was the only study to also examine the 
potential effects of post-traumatic stress disorder (PTSD) on intervention effect.  Rates of 





2. Engagement and predictors of engagement 
Four of the eight studies examined the impact of a BI on engagement issues for patients with drug 
misuse.  Two of the studies were SBIRT studies undertaken in the USA (Blow et al., 2010; 
D’onfrio and Degustis, 2010).  Also follow-up periods varied widely by study from 1 month 
(D’onfrio and Degustis, 2010) to 12 months (e.g Magill et al, 2009) 
Three of the studies found that those undertaking a BI were found to be more likely to engage in 
further treatment (D’onfrio and Degustis, 2010; Krupski et al., 2010; Tait et al., 2004, 2005a and 
2005b).  One of these studies however was descriptive (D’onfrio and Degustis, 2010) and did not 
have a follow-up period for all cases or a comparative control group. 
No differences were found between groups on characteristic predictors of engagement (older, 
insured, unmarried, unemployed and in the action stage of change) in the study by D’ Onfrio and 
Degustis (2010). Despite measuring predictors for engagement at baseline, Blow et al ( 2010) study 
did not report these results for engagement post intervention.  They did note that these outcomes 
will be reported in the future. 
It must be noted that in D’Onfrio and Degustis’ (2010) study,  assessment based patterns of use 
determined steps within the intervention.  Some participants were directly referred, while others 
were given information on referral dependant on risk.  They found that those who were directly 
referred were 30 times more likely to attend treatment.    However due to the short follow- up (1 
month),  and only high risk patients being directly referred  findings should be read with caution. 
BI’s in the ED were also found to impact on improving existing engagement for those already 
undertaking an intervention at 6 months post intervention (explored in one study only by Krupski 




3. Health and socio-demographic factors 
Significant self-reported improvements were reported in a number of heath and socio-demographic 
areas by one of the intervention groups (brief treatment group) in the study by Madras et al. (2009) 
and one study (D’onfrio and Degustis, 2010) elicited demographic factors that impacted on the 
odds of patients attending further treatment (patients who were older, insured, unmarried or 
unemployed) and in the action stage of change) 
4. Associated risk behaviours/Harm reduction 
Of the studies, that examined in full this outcome,  none found any significant difference in risky 
behaviour or employment of harm reduction between BI and control groups (Tait et al., 2004, 
2005a and 2005b; Woolard et al., 2013)  
5. Psychiatric symptoms and psychological wellbeing  
Two studies explored symptoms and wellbeing.  One (Tait et al., 2004, 2005a and 2005b) found 
improved scores on measures of psychological wellbeing for the BI group (regardless of 
attendance).  Although behavioural and psychological outcomes were also measured at baseline in 
the study undertaken by Blow et al. (2010), the authors offered no analysis of intervention 
effectiveness by way the repeat of measures post intervention or at any subsequent follow-up time 
points. 
6. Assessment reactivity 
One study (Bernstein et al., 2009) explored assessment reactivity but found no significant 





7. Repeat presentation to the ED 
One of the studies (Tait et al., 2004, 2005a and 2005b) found a significant reduction in return 
presentations to the ED for those who received the BI. 
















Outcomes for brief interventions in Inpatient psychiatric settings 
Five of the thirteen studies reported in this review were undertaken partially or fully with inpatient 
psychiatric patients. Four of the five studies were based in inpatient settings only and one was in 
multiple settings including inpatient wards.  All five studies were RCTs.  The intervention ranged 
from 1 to 6 sessions and ranged in session length from ten minutes to one hour.   
Please see page 29 for a summary table (table 4) of the research on brief interventions in 
psychiatric in-patient units. The table includes setting, study type, follow-up length, measurement 
and outcome. 
1. Levels  of drug and alcohol use (reduction and abstinence) 
 
Four of the five studies within the psychiatric impatient setting attempted to examine the 
interventions impact on levels of drug use (Baker et al., 2002; Kavanagh et al., 2004; Martino, 
Carroll,  Nich  & Rounsaville, 2006).  Follow-up periods ranged from 12 weeks (Martino et al., 
2006) to 12 months (Kavanagh et al., 2004).  Only one of the four studies measuring modification 
of drug use found a significant reduction in the participants receiving a BI (Kavanagh et al 2004).  
This was the study that included both the greatest number of follow-up periods (four) and the 
longest follow-up period length (12 months).  This Australian pilot randomised controlled trial 
(RCT) evaluated  a brief intervention in 13 first episode psychosis (FEP) patients and compared 
them with a control group of 12 FEP participants who received ‘treatment as usual’ (TAU) across 
three in-patient units.   The authors report the whole brief intervention group showing significant 
improvement in reduction in substance use at six months, up until one year compared with half of 
the TAU group.  The small sample size in this study is noted and indicates limited generalisability.   
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Table 4: Summary table of brief interventions for drug misuse in Psychiatric hospitals   
Author, 

















Measures Outcome  Quality 


















3  months 
 
(45%) 





Non-significant reduction of use in 
the MI group (slightly greater than 
the TAU group). 
 
No significant change in attendance 
to treatment. 
AA= Y AC=Y 
 BO=Y  BC= Y 
IA= U   KP= Y  
PC=Y  SR= N 







Inpatient RCT 121 patients 
 















Significantly higher initial 
outpatient attendance (first 
appointment) in the MI group 
AA= Y  AC=U 
BO= Y  BC=N 
IA=U   KP=U  
PC= Y  SR=Y  
OB=U   IT= Y 
 





Inpatient RCT 103 12-17 year olds 
 
 











1 month Knowledge of use 
 
Risk perception  
 
Intention to use 
Post Intervention: Significant rise in 
knowledge about drug use and 
perception of risk in intervention 
group post intervention. 
 
 
One month follow-up: Significant 
increase in knowledge about drug 
use in the intervention group Vs. 
control at one month follow-up. 
 
No significant differences were 
found between the groups for 
perception of risk or intention to 
use.   
AA= Y  AC= U 
BO=Y   BC=N  
IA= U    KP=U 
PC=Y  SR= Y 
OB=U   IT= Y 
 















4, 8 and 12 
weeks 
 
30 day Substance use 
Calendar at each time 
point (Frequency of 
Significant change across groups 
between baseline and 12 week 
follow-up. 
AA=Y  AC=Y  
BO= Y BC=Y  







































of and recorded of 




Weekly urine drug 
screens 
(>87% consistent 
















44% in primary drug use. 
 
40% in secondary drug use. 
 
37% in alcohol use 
 
No significant difference between 
all users in DDMI Vs. Si groups  
 
Primary cannabis users more likely 
to be male, younger and less 
motivated to change. 
 
Cannabis users significantly higher 
reduction of cannabis use amongst 
SI group (p=0.00) but no reduction 
of alcohol in both groups. 
 
Cocaine users significantly larger 
reduction across time points in the 
DDMI (80%) Vs. the Si (24.5%) 
group (p=0.01) 
 
Significant increase in medication 
adherence by 18.8 % across the 
sample (p=<0.01) but no significant 
difference between groups. 
(By sub group this remained for 
primary users of cocaine but not 
cannabis) 
 
No significant difference in 
treatment engagement but a trend 
towards DDMI group (79 vs. 55% 
admitted to the treatment) 
PC=Y  SR=N 





However no patient remained in 
treatment at 12 week follow-up. 
But how long was program meant 
to be? Rates of treatment entry and 






Addiction severity, psychiatric 
symptom and psychosocial severity 
significantly reduced across time 
amongst both groups (all p=<0.01).  
Negative symptoms = Significantly 
slower decline across time for the 
DDMI group (p=0.03) 
 




Readiness to change primary drug 
use and psychiatric problems there 
was no significant difference across 
groups. 
 
Interview experience (therapeutic 
alliance and satisfaction) rated 
highly and no significant difference 






Inpatients RCT Pilot 25 18-35  with a 









6 weeks & 3, 
6, 12 months 
 
25% 




Significantly greater reduction in 
use in the intervention group at post 
intervention and 12 months 
compared with the TAU group. 
 
AA= Y AC= Y 
BO=Y  BC=Y  
IA= Y KP=Y 
PC=Y SR=Y 








Non significant improvement in 





BI- Brief Intervention, BNI- Brief Negotiated Interview, BA= Brief advice, TLFB- Time Line Follow Back, SBIRT- Screening Brief Intervention and Referral to 
Treatment, SBI- Screening and Brief Intervention, MI- Motivational Intervention, DDMI- Motivational Interviewing adapted for dually diagnosed psychotic and drug-
related disordered patients. 
Quality key:- 
AA= Allocation adequately generated, AC= Adequate allocation concealment, BO= Baseline outcome measurements similar, BC= Baseline characteristics similar, IA= 
Inadequate outcome data adequately addressed, KP= Knowledge of allocated interventions prevented, PC= Protection from contamination, SR=Free from selective 




In contrast to the smaller sample of Kavanagh’s pilot RCT, another Pilot RCT by Martino et al. 
(2006) randomised participants to either a dually diagnosed motivational interview (DDMI) or 
treatment as usual in the form of a standard psychiatric interview (SI). The 24 DDMI and 20 SI 
patients both received two one hour sessions of their allocated intervention.  All patients were 
followed up at 4, 8 and 12 weeks.  However attrition was large, follow-up short and the study 
recruited from both in and outpatient services.      Martino et al (2006) found no significant 
differences between the groups or across time points.   Both groups were found to have made 
changes for the primary outcome measures of reduced frequency of primary drug use (44%), 
secondary drug use (40%) and alcohol use (37%).  Despite no significant differences for whole 
groups when regression analysis was undertaken by sub groups for primary drug use patients those 
who used cocaine in the DDMI group were found to have significantly reduced their primary drug 
use in comparison with their contemporaries in the SI group.  Numbers for analysis however were 
small (N=25) and this was acknowledged by the authors.  Unfortunately other class A drug 
subgroups could not be separately analysed due to very small numbers.  Interestingly cannabis 
users in the SI group were found to have reduced the frequency of their cannabis use over time 
points significantly more than the DDMI group.  Both cannabis subgroups (N =13) however did 
not reduce alcohol use.  The authors do note the non-secondary drug use and low baseline use of 
alcohol amongst the DDMI group limiting the possibility of between group effects for these 
variables. 
Although some of the studies were able to identify slight trends in a greater reduction in levels of 
drug use for intervention cases the difference was generally not large enough to be significant.  For 
example Baker et al’s (2002) study was not significant.  However when analysed for single 
substance abusers, alcohol and amphetamine use actually reduced more in controls that the 
intervention group.   For cannabis use again a non-significant difference in mean scores was found 
in the short term for the BI group.  At the longer time points of six and 12 months no substances 
resulted in reduced use in the intervention group compared to controls. 
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2 Engagement and predictors of engagement 
Three of the five studies undertaken in the inpatient psychiatric settings measured change in 
engagement with substance misuse treatment as an outcome of the BI (Swanson et al., 1999; Baker 
et al., 2002; Martino et al., 2006). It is evident that none of the studies explored engagement with 
mental health services as an outcome in this dually diagnosed population.  Swanson et al. (1999) 
compared the efficacy of a one off 60 minute brief motivational intervention with treatment as 
usual for 121 psychiatric inpatients.  They found statistically higher attendance to the first 
outpatient appointment for the intervention group compared to the control group, indicating the 
benefits of brief intervention in supporting engagement to continued psychiatric care in the 
community.  
As with levels of use, again although some studies reported a trend towards participants receiving 
the intervention engaging more than controls at follow-up, these studies findings did not indicate a 
significant difference in comparison with control groups (e.g. Baker et al 2002; Martino et al 
2006).  However what constitutes a control group and potential confounders are contemplated.  
Details of control group conditions show that whilst some patients received TAU others receive 
what may be considered interventionist treatment.  For example in the 2002 study by Baker et al. 
(measured levels of engagement in an outpatient specialist substance misuse services) controls 
received a self help booklet about drug use. 
3. Knowledge and awareness (of drug use and risks) 
Only one of the studies in the inpatient setting looked at an increase in knowledge about the 
negative impacts of drug use as an outcome of the intervention.  In Goti et al’s 2010 RCT pilot of a 
one off BI with 103 Spanish teenagers. Outcome was measured in terms of awareness of 
knowledge, awareness of risk and intention to use substances.  At follow-up knowledge about drug 
use and perception of risk had significantly risen within the intervention group. This remained 
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significant, compared to controls for overall knowledge only.  No significant differences were 
found between the groups for perception of risk or intention to use.  The follow- up for this study 
however was relatively short (one month).  The authors did note they were exploring short term 
effectiveness.   
4. Associated risks/Harm reduction 
One of the five studies explored reduced harm as an outcome.  Kavanagh et al. (2004) found there 
was a significant change in substance related harm at 6 months for the BI group compared to the 
TAU group.   However when intention to treat analysis was undertaken including those 
participants who did not receive part of the intervention this outcome lost significance. 
5. Socio-demographic factors  
One study looked at socio demographic differences in impact of a BI amongst dually diagnosed 
patients.  The study by Martino et al. (2006) found demographic differences by sub groups were 
not found in class A drug using subgroups but were found for cannabis users who were found to be 
more likely to be younger, male and less motivated to change (illustrated in lower URICA scores).   
6. Medication adherence 
Only one of the five studies in this setting explored medication adherence as an outcome measure.  
Martino et al. ( 2006) examined any changes in medication adherence for the BI group and found a 
significant increase in medication adherence by 18.8 % across the sample (p=<0.01) but no 
significant difference between groups.  When they further examined this outcome by drug of 
choice they found the effect remained for cocaine users but not cannabis users in the BI group. 
7. Quality of life/functioning 
Again the study by Martino et al’s (2006) was the only study to report on quality of life for 
participants undertaking their research.  The study found no difference in quality of life and 
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functioning for the BI group over TAU.  An increase in general function across all groups (p=0.01) 
was found.  
8. Psychiatric symptoms 
Mental health symptoms were measured and reported on by one of the five studies.  When 
evaluating  psychiatric symptom and psychosocial severity  Martino et al. (2006) found these 
outcomes significantly reduced across time amongst both groups (all p=<0.01).  Negative 
symptoms were additionally significantly slower decline across time for the DDMI group (p=0.03).  
Due to the short follow-up period and small sample size of this pilot study the results are read with 
caution. 
9. Participant experience 
Martino et al’s (2006) pilot was the only study to report on participants’ satisfaction with the BI 
and found therapeutic alliance and patient satisfaction to be high.  This was found for both groups 











Comparison of settings: Summary and quality of evidence 
The following section will compare the findings and methodological issues of the studies in both 
areas.  As already discussed although they are many quality frameworks for both quantitative and 
qualitative studies the need to explore the quality of all identified studies unrestricted it was 
decided to utilise guidance on quality reviewing from the Cochrane Handbook to assess the 
methodological quality of the selected studies.  The research studies reported in the previous 
section show that there is diversity in the findings of the effectiveness of brief interventions in both 
of the acute inpatient settings reviewed.   
Outcomes for brief interventions in the ED setting appear to focus on two main areas;  
1. Modifying drug use and reducing associated risk behaviours.  
2. Engagement with substance misuse treatment in the community.  
 
In comparison outcomes for brief interventions for drug use in the inpatient psychiatric settings 
appear to focus on one of three main areas;  
 
1. Modifying drug use and its impact on mental health.  
2. Engagement with integrated treatment for substance misuse and mental health difficulties.  
3. Modifying intention/readiness. (psychological change) 
 
This review is generally consistent with the findings of other literature reviews on the efficacy of 
brief intervention with patients with a health difficulty and co-existing substance misuse.  Physical 
health as a co-morbidity (studies in the ED) resulted in slightly larger changes than mental health 
as a co-morbidity as found previously by Kaner et al. (2011). 
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Results in terms of positive change in outcome varied for both the psychiatric inpatient setting and 
the ED.  Levels of drug use were modified in slightly more of the ED studies for the BI group 
compared with the TAU groups.  In comparison many of the in-patient studies showed either no 
significant change or no change over and above treatment as usual. In relation to the most 
commonly measured outcome, levels of use, non-significant trends were sometime found in the 
psychiatric inpatient studies.  This difference may be explained by the difference in sample sizes 
for the two settings.  Sample sizes in the inpatient setting tended to be much smaller and many of 
the studies were pilots.  This type of intervention study with patients with DUDs (not just alcohol 
use) is fewer and less established in the inpatient setting compared with the ED. 
Many of the psychiatric inpatient studies had considerably smaller sample sizes than the ED 
studies.  For example the study by Martino et al. (2006) has quite a small sample size of 44 (25 
cocaine users, 13 cannabis users, 2 Heroin users and 4 Ecstasy users) thus results must be 
interpreted with caution.  In addition unfortunately the paper does not report the percentage of 
participants from each setting (in and out patients) resulting in the reader being unable to 
distinguish any differences by patient setting.  However the study does not provide favourable 
findings to support the efficacy of brief motivational interventions for patients with mental health 
difficulties and co-existing drug use over and above treatment as usual. When undertaken for 
specific drugs, such as the differences for cocaine users there is some merit for the motivational 
brief intervention used in the study.  With few studies evaluating brief interventions in acute 
inpatient settings and specifically focusing primarily on illicit drug use it would be difficult to 
provide a consensus on their usefulness.  The picture remains unclear due to diverse methods and 
small sample sizes.  Martino et al. (2006) make a valid point regarding the idea that generic brief 
interventions may not work equally well with research samples that, to date, have consisted of 
participants taking a variety of different illicit drugs.  They advocate the need for brief 
interventions that target by drug type.  This is not to say studies where drug type varies are 
redundant.  Larger sample sizes where researchers are able to stratify analysis by drug type would 
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prove just as beneficial in the goal of evidencing efficacy in all types of inpatient health settings.  
Some of the inpatient studies in both settings lacked specificity when it comes to the 
content/definition of the brief intervention and confirmation that the intervention was manualised. 
From analysis of the research papers there is a need to clarify treatment as usual (TAU) from 
‘manipulated’ TAU.  Some of the studies (e.g. Martino et al., 2006) were clear in what their control 
groups received but others were not (e.g. Swanson et al., 1999)  and on closer inspection there was 
some elevated element to true treatment as usual (e.g. an educational information leaflet).  It is 
argued that this would then impact upon achieving true clarity on the potential impact of the 
intervention and differences in outcome by group.  Goti et al., 2010, for example, were one of the 
few studies to acknowledge the potential influential effects of their ‘TAU’ group. Research has 
shown that TAU can vary widely with implication for the outcomes of efficacy studies such as 
RCT’s when TAU groups are used as comparators and/or controls (Lofholm et al 2013).  This in 
turn has implications for the ‘evidence’ utilised in evidence based practice.  
Although not explicitly discussed in each paper, profession and training length and quality may 
have impacted the intervention delivery and thus the results. Additionally follow-up length varied 
widely for studies in both settings.  The ED studies had marginally longer mean follow-up times 
than inpatient studies.  In terms of acceptability of such interventions to staff and patients, a study 
by Sise et al. (2005) found both staff attitudes positive and patient satisfaction high for the ED 
based brief intervention they tested.   
Methodology varied by setting.  Protocols for RCTs for example generally gave more detail in the 
ED papers compared with the psychiatric inpatient papers.  Bogenschutz et al. (2009) reported on 
the design protocol for a randomised control trial of brief intervention in the ED setting. They note 
the challenges in constructing suitable research design and issues to consider such as the 
appropriate selection of inclusion criteria, research outcomes and analysis as well as appropriately 
defining treatment conditions, settings and study population.  Also attrition rates varied by setting 
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in both the ED and psychiatric setting.  For example in Baker et al. (2002) inpatient study  26% of 
the M.I group and 29 % of the control group (55%t of the total sample) were followed up at all 
time points.  For BIs over multiple time points it was noted that less of the psychiatric samples 
completed the full intervention in comparison to the ED, which were mostly one off BIs.  For 
example in Kavanagh et al. (2004) study in a psychiatric unit only 8 out of the 13 BI participants 
completed the intervention.  The authors do not however discuss the effects on their findings in 
relation to this. 
Treatment reactivity was considered as part explanation for some of the study outcomes (in both 
settings) been similar for condition and control groups.  Although studies continue to show the 
insignificant effects of treatment reactivity in brief interventions for substance use (Marsden et al 
2009) this was not found by the one study evaluating it in an ED setting (Berstein et al., 2009).  In 
comparison no studies in the psychiatric setting assessed assessment reactivity or reported on the 
potentially confounding impact.   
The difference in results by setting maybe explained by the type of patient participating in the 
research studies.  It would be thought that people presenting to the ED would be more varied in 
terms of severity of symptoms of mental health and wellbeing.  In comparison those admitted to 
the inpatient psychiatric setting present by the stage of admission with more severe or chronic 
mental health presentations, hence substance misuse and maintaining beliefs about drug use may 
be more entrenched and harder to shift.  It could be argued that this would then impact on readiness 
to change and the impact of any BI undertaken. Reduced insight may be another reason for 
differential outcomes in the two settings, with those in the psychiatric inpatient setting being most 
impacted (i.e. poorer insight).   The window of opportunity is much smaller in the ED setting in 
comparison with the psychiatric in-patient setting and the lack of insight in the latter setting may 
also explain varied results.  The theorised sealing over recovery style (McGlashen and Levy, 1977)  
was conceptualised for severe mental health.  It is questioned  at precisely which stage psychiatric 
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patients begin to utilise this style during the inpatient stay and  how the BI aligned to this process.  
Only one paper measured readiness to change and none measured recovery styles, help seeking 
behaviour or insight. In future studies measuring these factors as potential predictors may be 
beneficial to appropriate and targeted brief interventions. 
Strengths and Limitations of this review 
This review limited the exclusion of research studies based on quality due to the limited number of 
papers in the area.  The author is therefore aware of the limitations of the varied methodology and 
quality of the studies used to draw conclusions on the benefits of brief intervention in the examined 
area.  However  research  is  limited in this area and  all methodological studies which fit the 
review criteria were included the review was as inclusive as possible given the limited number of 
studies and the sole reporting of  RCTs would have resulted in a number of informative studies 
being excluded. 
Despite this a limitation of this study may be that by combining poorer quality studies with better 
quality ones this may have led to some obscurity of true effectiveness of such interventions.  
However and counter to this suggestion, if only the highest quality studies such as RCT’S were 
included they too have their own limitations (such as the overuse of heterogeneous samples,  single 
morbidity samples etc.) which are argued to impact upon the ecological validity of findings (Slade 
and Priebe, 2001; Cartwright, 2007).  It has been argued that even the most rigorous RCTs cannot 
give a comprehensive evidence base and other established methodologies must also be considered 
(Slade and Priebe, 2001). 
As already discussed due to the small number of studies within this area and setting it was decided 
all studies were included that evaluated empirical efficacy.  It may be that this led to little selection 
bias of the experimental studies.  This review was about reporting research available on 
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intervention effectiveness rather than attempting to give a definitive view on their merit in such 
settings for drug use.   
This review, as with many others, faces the bias in reporting due to selective publication.  Despite 
the value of null hypothesis it is widely acknowledged that it is still the case that many journals 
more readily publish studies where, an often significant, change has been found.  It is unknown 
how many studies that have been conducted yet found no significant difference lie unpublished and 
unreported.   Similarly the bias of reporting only on a subsection of data within a larger dataset 













Summary of the evidence. 
Findings of this review on the efficacy of brief interventions in inpatient settings for drug misuse 
reflects similar findings from other recent reviews on the effectiveness of brief interventions for 
substance misuse (e.g. Kaner et al., 2011).  Brief interventions undertaken in the ED were 
generally found to effectively impact upon outcomes (predominantly level of use) more 
consistently than brief intervention undertaken in the inpatient psychiatric wards. Similarly Kaner 
et al date found generally positive outcomes for BI’s for physical health and substance misuse and 
ambiguous outcomes for mental health and substance misuse. 
Type and length of brief interventions in both settings were found to vary widely along with 
methodology such as sample criteria and outcome measures. Is there a need to redefine what 
constitutes a brief intervention?  If researchers were to evaluate the efficacy of a more streamlined 
definition of BIs with more comparable methodology and sample inclusion criteria perhaps more 
homogenous results may be found.  Perhaps the lack of such specificity as to what type of brief 
intervention is used in research amongst this population would inevitably only yield such 
heterogeneous results until researchers consistently evidence specific types of brief intervention 
(feedback or MI).  There is a need for future studies to look at the validity of the constituent parts 
of B.Is. 
Limited findings for drug misuse in these settings, as Higgins and Green (Cochrane Manual, 2006) 




Recommendations and considerations for clinical practice and future research. 
It is clear from SAMSHA’s SBIRT initiative in primary care and emergency medical settings that 
the United States of America are somewhat ahead of the United Kingdom in terms of having a 
comprehensive and, to some extent, consistent approach to substance misuse interventions in 
physical health settings.  It is suggested that there is now a need for a move towards a similar 
approach here in the UK, in both mental and physical health.  Although there are inpatient settings 
in the UK (mainly EDs) utilising brief interventions in the UK, to date, this is far from standardised.  
In order for this to take place staff must be more uniformly trained in brief interventions as a model 
integral to the work they already do.  Whilst potentially seen as an ‘extra’ burden on workload an 
additional requirement of knowledge and skills clinical application will remain limited.  According 
to NICE clinical guidance (Clinical Guidance 51, 2007) interventions offered in the community 
should also be available to patients in inpatient settings. 
All countries would also benefit from firstly, focusing BIs equally on drugs as well as alcohol 
misuse in inpatient settings (not just outpatients) and secondly applying more focus to mental 
health settings as well as physical health settings.  Much of the current research is still alcohol 
focused. Further in-patient research specifically focusing on brief interventions for illicit drug use 
is needed.  However the need for measurement of the right outcome is the key in order for the brief 
interventions to be deemed to be of benefit in acute inpatient settings. 
There is a need for larger sample size RCT’s in psychiatric inpatient settings in particular.  Both 
small sample sizes and small effect sizes within BI research (Kypros, 2007) will continue to impact 
studies unless this is done.   Both settings may also benefit from more qualitative studies regarding 
the internal (psychological) and external (practical) factors that impact on motivation to modify 
substance use and engagement with clinical services both in hospital and in the community. 
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As brief interventions can in fact result in very varied interventions it is important for comparisons 
to be made of studies that have similar methodologies and interventions (i.e. content, length, 
outcome objectives) in order to be able to get a clearer picture of the efficacy of brief interventions 
in acute in patient settings and the components of the intervention that lead to significant change.  
Longer follow-up times are also needed in order to achieve more valid and reliable findings. 
None of the research explored help seeking behaviour, recovery styles, insight or beliefs about 
coping amongst research samples.  This may be a helpful move towards greater understanding of 
what personal factors aid change when brief intervention are offered in inpatient settings.  BIs are 
not the panacea for all change in substance misuse in inpatient setting but the brief nature and cost 
effective benefits of such intervention could surely be utilised more should future clearer evidence 
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Testing a brief psychological intervention for in-patients with co-existing mental 













Aims: This study sought to test the feasibility and impact of a brief intervention for clients with 
coexisting mental health and substance misuse difficulties in an in-patient psychiatric setting.   
Methods: 11 participants were recruited to the study from three in-patient psychiatric ward.  A case 
series design encompassing a pre-intervention baseline assessment period, a brief integrated 
motivational intervention and post intervention assessment (immediately following the intervention 
and approximately one month after).  Analysis was undertaken using the reliable change index 
(RCI) (Jacobson and Traux, 1991) and analysis of themes from a brief post intervention semi-
structured interview. 
 Results: Analysis of the eight of the 11 cases followed up (4 intervention and 4 non-intervention 
cases) showed no significant difference between the groups who reported little change in process 
or outcome variables following the intervention.  In contrast, a number of cases from both groups 
reported reduced substance use. 
Discussion:  The brief integrated motivational intervention appeared to be feasible for those 
patients whose length of stay spanned the intervention.  Difficulties in implementation such as 
attrition due to discharge and follow-up in the community were identified along with the need for 
more sensitive measures for this population.  Issues for implementation and future research are 
discussed. 
 
Keywords:  Brief Intervention, Substance use disorder (SUD), Substance misuse, Severe mental 







Severe Mental Illness and Substance Use disorders 
The prevalence of substance use disorders (SUDs) amongst people experiencing severe mental 
illness is a common occurrence (Reiger et al., 1990; Kavanagh et al., 2004; Public Health England, 
2012) and has been increasingly investigated over the past ten years. Severe mental illness (SMI) 
and co-existing SUDs has long presented a challenge for clinicians.  This type of co-morbidity has 
been found to impact on treatment outcomes (Laker, 2007).  Many UK and worldwide studies have 
found those with mental illness at increased risk of misusing substances and this substance misuse, 
in turn, affecting symptoms and recovery, increasing chance of relapse, increasing rates of in-
patient admission (Bartels et al., 1993)  and reducing treatment compliance, amongst other adverse 
effects (Cleary et al., 2008).   
Epidemiological studies such as Kavanagh et al (2004) have found that being male and young was 
most significantly associated with SUDs in people with co-existing severe mental illness.  
Substance misuse profiles have been found to differ by gender (Norberg et al., 2012).  The 
COSMIC study (Weaver et al., 2002) found as many as 44% of Community Mental Health Team 
(CMHT) patients reported SUDs difficulties. Additionally 75% of drug service users and 85% of 
Alcohol services users were identified as having a ‘psychiatric disorder’.  Even small amounts of 
illicit drugs have been found to be detrimental to metal health of those with existing illness 
(Kavanagh et al., 2004).  Despite historical difficulties with cohesive care from mental health and 
substance misuse services (Drake et al., 2003) a model of integrated care is now evidenced (Drake 
et al.,1998; Ho et al., 1999; Barrowclough et al., 2001) and advocated as best practice (Department 
of Health, 2002; Nice 2011). 
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Sealing over and windows of opportunity 
It is thought that in-patient settings are the opportune environment to attempt engagement and 
fostering of motivation to change substance use amongst individuals with SUDs (Department of 
Health 2006).  McGlashan et al (1977) identified the concept of sealing over, in which individuals 
may minimise the significance and reality of a recent episode of psychosis as a method of coping 
with the distress and impact of their psychosis.  This recovery style following the onset of an 
episode of psychosis has been found to predict poor treatment engagement (Tait, Birchwood and 
Trower, 2003; McGlashan, 1987).  Between the periods of first admission and sealing over it is 
theorised that as patients psychiatric symptoms become more stable they become more reflective 
on their mental health and reasons for admission.  This is thought to provide a possible window of 
opportunity for psychological work.   
A model of change  
Individual behaviour change is the overarching aim when attempting to change the impact of SUDs 
on health. One of the most commonly utilised models of change within SUDs is Prochaska and Di 
Clemente’s trans-theoretical model (1992).  The model suggests that individuals can experience a 
variety of difficulties at different levels (e.g. symptom/situational, maladaptive cognitions, 
interpersonal conflicts, family/systems problems and interpersonal conflicts.)  This can aid in the 
understanding of both why difficulties occur and areas for intervention.  
The model asserts that change is a continuum of active processes.  In order for individuals to 
achieve a change in behaviour they go through/experience a number of stages of change (Pre-
contemplation, contemplation, preparation, action and maintenance.  Underlying the stages of 
change are ten processes that assist an individual’s movement between stages (e.g. consciousness 
raising, self re-evaluation, counter conditioning etc.). The model is extensively used in the 
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treatment of drug and alcohol use and is adopted in many other fields such as physical health 
treatment and psychological interventions for mental health treatment.  
Readiness to change and motivational interviewing 
Ambivalence is thought to be a pre-requisite to behaviour change in people with SUDs.  Being 
motivated to make a change in one’s drug and/or alcohol use, also known as readiness to change, 
can be encouraged by first highlighting the presence of ambivalence and then working on reducing 
it.  Motivational interviewing is one method used aiming to achieve this.   
Motivational interviewing is an approach originally developed to help problem drinkers (Miller 
1983). The approach seeks, through a collaborative and allied discussion between client and 
worker, to identify and highlight a patient’s ambivalent position regarding their substance misuse 
and to enhance readiness to change (Miller, 1991; Hettema, Steele and Miller, 2005).  Motivational 
interviewing is often wrongly identified as a specific intervention or technique (Miller and 
Rollnick, 2009) when in fact its proponents William Miller and Stephen Rollnick identify it as a 
concept that can be utilised in SUDs treatment.   
“Motivational interviewing is a directive, client-centred counselling style for eliciting behaviour 
change by helping clients to explore and resolve ambivalence.” 
(Rollnick and Miller, 1995, page 325)   
MI is often used in brief interventions (BIs with the aforementioned group with the objective of 
increasing motivation or readiness to change and risk awareness (of the impact of SUDs on their 




Brief Interventions (BIs) are varied in content and format.  Research methodology used for 
evaluation and resulting findings on brief interventions have also been found to vary.    A number 
of research papers in the last fifteen years have attempted to evaluate the usefulness of utilising 
brief interventions with this co-morbid population (Kaner, Brown and Jackson, 2011; Goti et al., 
2010; Laker, 2007; Hulse and Tait, 2002; Baker et al., 2010; Kavanagh et al., 2004; Graeber et al., 
2003; Daley et al., 1998).  Some studies of brief interventions for severe mental illness and co-
existing SUDs have found significant beneficial effects over time. For example  Hulse and Tait 
(2002), evaluated a one off 45 minute motivational style brief intervention against an information 
only control group (who received an information only package on safer alcohol consumption 
patterns) on three in-patient wards. They found a significant difference in alcohol consumption in 
the intervention group compared with control groups at follow-up  whilst other studies have found 
no significant benefit over treatment as usual (e.g. Martino et al., 2006). 
Whilst recent research suggests some benefits of brief interventions there remain many unanswered 
questions. For example, which types of brief intervention are most effective, over what time period 
and which outcomes are most likely to be improved with brief interventions? What are the effects 
of short burst brief interventions for example, which range from 10-30 minutes at a time. This 
aforementioned type of brief intervention is more commonly used with clients experiencing 
physical health and SUDs. In one of the most recent UK systematic reviews of the effects of brief 
interventions for co-morbid populations Kaner, Brown and Jackson (2011) evaluated both 
methodological quality and research outcomes for 14 brief intervention trials for people 
experiencing co-morbid difficulties. The eight trials concerned with SUDs and SMI showed 
greater, yet non-significant, improvement in intervention groups compared with controls. However 




Some authors have noted the need for more research examining the efficacy of such brief 
interventions (Kaner et al., 2011; Kavanagh et al., 2004). Carey et al’s (2002) pilot study 
evaluating the viability of a four session brief motivational intervention as part of treatment for 
outpatients with mental illness and SUDs concluded that the efficacy of such interventions may lie 
in their use as an initial part of more extensive treatment.   Many studies focus on community 
patients thus possibly under-utilising the window of opportunity towards the end of in-patient 
admission where clients may be more reflective and willing to engage.  It is argued that, as in 
hospital emergency departments, brief interventions could be utilised both as preparatory work and 
as a motivating tool to engage patients in longer term integrated community care (Goti et al., 
2010).  The UK’s National Institute for Health and Clinical Excellence (NICE) quality standards 
for drug use disorders (NICE, 2011) note that many people with SUDs have co-existing mental 
health difficulties and need simultaneous treatment of both disorders in order for the most effective 
outcome.  They recommend BIs as a ‘first line’ method of treatment. 
This current research examines whether difficulties with readiness to change and engagement may 
be exacerbated in patients with co-existing SUDs.  
A model of Intervention for Dual diagnosis: Cognitive Behavioural Integrated Treatment (C-
BIT)  
Cognitive Behavioural Integrated Treatment (C-BIT) is a model of intervention developed 
specifically for patients with SMI and SUD (Graham et al., 2004).  This model follows the mode of 
integrated treatment simultaneously for both an individual’s SUD and the impact on their SMI (e.g. 
symptom severity and triggers for relapse).  Following assessment  C-BIT employs both 
motivational interviewing and cognitive behavioural therapy at four stages of treatment with the 
aims of firstly encouraging therapeutic engagement, secondly eliciting and negotiating change in 
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SUD behaviour change, Thirdly  teaching initial relapse prevention and lastly solidifying relapse 
prevention and management work.  C-BIT is used in both in-patient and community settings and 
utilises a consultation model for staff teams to undertake direct intervention work with clients.   
Figure 1: Cognitive Behavioural Integrated Treatment (C-BIT) Model, Graham et al (2004) 
         
                      
Dr Graham and colleagues have designed a Brief Intervention adapted from the C-BIT model. 
 Aims of the Present Study 
The present study was designed as a first step to test a Brief Intervention (BI) with clients with 
coexisting mental health and substance use difficulties, admitted for  in-patient treatment.  A series 
of case studies aimed to explore the viability of using the in-patient stay as a window of 
opportunity to engage clients in a BI before discharge.  Based on the available evidence this pilot 
study intended to investigate the impact of the BI on key psychological processes and outcomes of 
change in an in-patient   population.  The study sought to test processes of insight, importance and 
confidence to change as well as monitoring for any change in important outcomes such as 
Stage 1 
Engagement and 


















readiness to change and engagement with treatment as usual.   
Research questions 
The following research questions were explored: 
1) Is the Brief Intervention (BI) viable in an in-patient setting? 
 
2) Can a BI utilise the window of opportunity in the in-patient stay to impact on the 
constructs that have been identified as helping people contemplate change and take action 
to change substance use?  These processes included : 
a. Importance of change  




3) Will the brief intervention impact on outcome variables. Namely: 














A case series design was undertaken. Measures of multiple variables (primarily subjective 
processes of confidence, importance and insight and outcome measures of readiness to change and 
engagement before and after intervention) were administered to eleven research participants. Each 
subject served as their own control.  This design was chosen as an appropriate way of testing some 
of the identified psychological processes involved in motivation and specific outcomes of the 
intervention with the patient numbers available and time scale of this study. 
Participants and setting  
Eleven patients who were admitted to one of three acute in-patient psychiatric wards (all within 
one unit) located within Birmingham and Solihull Mental Health Foundation Trust (BSMHFT) 
were recruited to the study.   Six began the intervention.  Ethical approval for the current study was 
granted by South Birmingham Local Research Ethics Committee (Reference number 
12/WM/0171).  Further approval to undertake the research at these targeted sites was granted by 
BSMHFT research and development department.  
All participants were diagnosed with severe mental illness (SMI) (namely psychosis or bipolar 
affective disorder) and co-existing substance use disorders (SUDs), namely abuse or dependence 
on illicit drugs or alcohol.   All participants were recruited over a 7 month period.  
Inclusion criteria included: 
1. Individuals aged between 18 and 64 years old 
2. Individuals with a diagnosis of psychosis related mental illness and with co-existing SUDs. 
3. Harmful or hazardous substance use in the last 30 days prior to admission (alcohol and 
illicit drugs. Not cigarettes).  
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4. Individuals admitted to the target in-patient settings. 
5. Individuals fluent in English. 
 
Those who had participated in similar research in the last five months, were not fluent in English or 
lacked legal capacity were excluded from the study.  
Procedure 
Information and consent  
Ward staff were briefed on the research and its inclusion and exclusion criteria. Patient screening 
and discussions between staff and the researcher then led to the identification of individuals who 
met inclusion criteria. Sometimes additional clarity was sought from patients regarding their 
substance use.  Following confirmation that the potential participant was suitable and able to 
consent the researcher was introduced and began the process of offering participant information.  
Potential participants were given the opportunity to discuss the information and have any questions 
answered before consent was sought to participate.  Confidentiality, research being separate to 
their clinical care and the right to withdraw at any time was emphasised.   
Following consent, arrangements were made between the ward staff, the participant and the 
researcher for the researcher to attend the ward at agreed time points to undertake the intervention.  
Regular updates regarding capacity and risk were undertaken.  All participants still received 
treatment as usual, as a minimum, for their primary diagnosis.  Research contact was undertaken 
by the principal researcher over four weeks and consisted of: 
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Pre-Intervention Baseline Research Assessment 
Before the intervention began the researcher sought good communication and facilitation with 
ward staff.  This in turn assisted the researcher in building a positive and engaging relationship 
with participants undertaking the intervention. 
Two pre intervention assessment sessions were completed in order to undertake baseline 
measurements of substance use and the constructs previously described. Socio-demographic 
information will also be sought. Each of these sessions lasted between 30 and 45 minutes 
approximately. 
Intervention 
A structured brief integrated motivational intervention based on the early stages of the Cognitive 
Behavioural Integrated Treatment (C- BIT) package (Graham et al 2004) was then administered 
over four sessions.  The brief intervention (BI) had an integrated focus on mental health and 
substance use and aimed to map onto the client’s stage of change and recovery. The beginning of 
the motivational style brief intervention focused on engaging the participant, and  offering psycho-
education and feedback. The intervention also aimed to create cognitive dissonance.  The next 
stage of the intervention aimed to encourage contemplation to change problematic substance use 
and to engage with treatment services.  Potentially,  plans for change were also explored as well as 
the benefits of supportive social networks.  Details of the intervention content can be found in 
appendix 11 (Additionaly the manual is available on request from the author).  The intervention 
was delivered by the principal researcher.  The researcher received training in delivering the 
intervention.  Standards and fidelity to the model were monitored by research supervisors through 
regular discussion and feedback in supervision. 
67 
 
Post Intervention Research Assessment 
One post intervention session was undertaken to re-administer all previous measures and conduct a 
brief 20minute semi-structured interview with the participant regarding their views about taking 
part in the intervention. Participants’ perceptions of undertaking the brief intervention, any 
ambivalence and any motivational and/or change statements were explored.  Total time was 
approximately one hour. 
If patients gave consent to follow-up the researcher made contact one month post intervention in 
order to conduct the assessment.  This session lasted between 30 and 45 minutes.  Participants who 
were discharged before research could be completed were contacted in the community where 
follow-up assessment was undertaken. 
Measures  
Mental Health Diagnosis  
The participant’s mental health diagnosis was established through their record of existing clinical 
diagnosis at time point one. 
Substance misuse information (Level and frequency of use and age of first use) 
Maudsley Addiction Profile (MAP) Marsden et al., 1998 
The MAP is a four domain outcome measure of substance misuse, health risk behaviour, physical 
and psychological health.  The first domain only was used to screen for current frequency and 
quantity of substance use for the 30 days prior to admission and age of first use. 
 Outcome and Process measurement 
The complete set of measures used in the study are described in detail within Table 1. 
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The Stages of Change 
Readiness and Treatment 
Eagerness Scale 
(SOCRATES) 








Scores range from 4-20. High scores 
indicate high levels of ambivalence and 
uncertainty about whether substance 
misuse is an issue, is causing harm or 
needs to change.  This curiosity may be 
anticipated in the contemplation stage 
of change.  Low scores indicate a lack 
of curiosity which may be either a high 
or low recognition that use is 
problematic (Miller and Tonigan, 
1996).  The hypothesis predicted an 
increase in ambivalence or lowering in 









Scores range from 7-35. High scores 
indicate recognition of the harms of 
substance use and the need to change 
use. Low scores indicate denial of these 
issues or the need to change.  It was 
hypothesised that recognition would 








Scores range from 8-40.  High scores 
indicate some positive change has 
already occurred and/or the need for 
help with changing has been 
acknowledged.  Low scores indicate no 
action to change.  The study posited 
that taking steps scores would increase 
after the intervention period. 
 
Substance Abuse 
Treatment Scale (SATS) 






The treatment scale scores range from 1 
to 8. A score of 1 indicates no 
engagement with SUDs treatment.  
Increasing scores indicate an increased 
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Ackerson, 1995  level of engagement with services and 
reduction in use. The highest score of 8 
indicating that the client is in long term 
recovery and does not meet criteria for 
SUDs.  Hypothesis was made that 
SATs scores would increase following 
the intervention. 
 
Severity of Dependence 
Scale (SDS) 





The measure indicates the severity of 
substance use. Scores range from 0-15.  
The cut off for problematic substance 
use is 3.  The higher the score the 
greater the severity of dependence.  
Hypothesis did not focus on severity of 
dependence but results are reported. 
 
Alcohol Use Disorders 
Identification Test (AUDIT) 








The Audit gives an indication of 
frequency, intensity and severity of 
alcohol use.  Scores range from 0-40.  
The cut off for problematic alcohol use 
is 8.  The higher the score the greater 
the severity. Hypothesis was not made 
regarding severity of use. 
 
Process Measures 
Scale Subscale Comment 










Both rulers are scored on a scale of 0-
10.  The higher the score the greater the 
subjective confidence or importance to 
change depending on which of the two 
measures is being considered.  The 
study hypothesis predicted that 
confidence and importance would 
increase over and after the intervention 
period. 
   
Insight Scale (IS) 





The insight scale total scores range 
from 0-12.  The higher the score the 
greater the insight into mental health.   





Awareness of illness 
 
Need for treatment 
are indicative of a patient’s better 
awareness of their mental health 
symptoms. 
Scores range from 0-4. Higher scores 
indicate a greater cognizance on the 
patients’ part that they are unwell. 
Scores range from 0-4. Higher scores 
are suggestive that the patient is more 
conscious of the need for treatment than 
a lower score which would indicate a 
lack of awareness. 
  
   













Data analysis  
The variables were analysed by comparing baseline performance scores with scores following the 
intervention. 
Analysis of reliable change 
The reliability and magnitude of change was analysed using the Reliable Change Index (Jacobson 
and Truax, 1991). The Reliable Change Index (RCI) is a measurement used to indicate the degree 
and direction of change for clients following therapy.  Statistically reliable and clinical meaningful 
change has been defined as the movement of a client from the range of the dysfunctional 
population towards or within the range of the functional population on a given outcome measure 
(Jacobson and Traux, 1991; Wise, 2001).  The RCI was additionally used to evaluate change 
during the baseline period (i.e., to establish that the baseline period was stable with respect to the 
measure in question.    Table 2 on page 72 describes the interpretation of reliable change scores. 
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Table 2: Terms and interpretations for Reliable Change Index (RCI) scores.  (Jacobson and Truax, 
1991) 
RCI Scores Label Interpretation 
<-1.96 Statistically reliable 
decline 
Significant deterioration for measures 
designed where a downward 
trend/reduction indicates worsening of 
condition. Score lies within the 
dysfunctional population. 
 OR  
Significant improvement for measures 
designed where an upward 
trend/increase indicates recovery. Score 
lies within the functional population. 
 
-1.66 to -1.95 Clinically meaningful 
decline  
Some reduction in scores indicating 
positive or negative change dependant 
on the measurement trajectory. Move 
towards the functional or dysfunctional 
population. 
 
-1.65 to +1.65 No change No variation or modification sufficient 
to indicate deterioration or 
improvement. 
 
+1.66 to +1.95 Clinically meaningful 
increase  
Some increase indicating positive or 
negative change or move towards the 
functional or dysfunctional population 
according to measure trajectory. 
 
>+1.96 Statistically reliable 
increase  
Recovered or greatly improved for 
measures designed where an upward 
trend/increase indicates improvement 
of the condition.  Score lies within the 
functional population. 
OR  
Significant deterioration for measures 
designed where a down trend/ 
reduction indicates worsening of 






Thematic analysis of the qualitative data was used. Common themes in the semi structured- 
interviews were identified, explored and later the qualitative findings were integrated to those from 























Screened Patients and Participants 
105 patients across 3 in-patient wards were screened as part of the current study.  The three wards 
consisted of a male acute ward, a female acute and a male acute psychiatric intensive care unit. 
Sixty percent of patients were male and 32% were diagnosed with schizophrenia. Thirty three 
(31%) of participants screened met the inclusion criteria for study participation.   Figure two 
provides details of the screening and recruitment process.  
Of the 22 patients who were eligible but did not consent 81% were male and a large proportion had 
a diagnosis of schizophrenia (73%).  Similarly a large percentage (73%) used cannabis as their 
main drug of choice.  This illustrates that those who consented were fairly representative of the 
total number of eligible patients.   
Eight of the 11 participants were successfully followed up; four intervention cases and four non-
intervention cases.  The  non-intervention group consisted of individuals who were considered 
suitable for the intervention but were discharged from the ward before the intervention could 
begin.  Outcomes from this group were used as a non-treatment comparison with the intervention 
cases. 
Figure 2 shows that 85% of the eligible patients (N = 33) were seen.  The other 5 eligible patients 
(15%) were not approached for information provision and consent as it was the opinion of their 
responsible medical officer that a high level of psychotic symptoms and/or present aggressive and 
violent behaviour made them unsuitable for this study.   Fifty-five percent of eligible patients were 
provided with the research information and 61% (11/18) of those given information consented to 
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 Not able to be seen 
(Risk) 
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Demographic and clinical characteristics of the participants 
A summary of the demographic, clinical characteristics and substance use characteristics of all 
eleven consenting patients is given in tables 3 and 4.  
Table 5 on page 78 illustrates the number of participants who completed each time point 
(assessment and intervention).  As already illustrated in the flow chart, 5 of the 11 participants only 
undertook baseline measures before being discharged.  The remainder of the sample undertook the 
baseline assessment and also began the intervention.  
Table 3: Demographic, clinical and substance use characteristics of in-patients who met the study 
criteria and consented to participate (N=11)  
 Frequency 




(N=11)  Participants followed up (N=8) 
  
Intervention 




     Sex     
         Male 9 (82%) 3 3 
         Female 2 (18%) 1 1 
    Age range (mean years) 21-59 (36) 26-59 (41) 21-50 (38) 
    Ethnicity     
         White/ White British 7 (64%) 2  3  
         Black/ Black British 2 (18%) 1 0 
         Indian/Pakistani 2 (18%) 1 1 
   Employment status    
        Employed 2 (18%) 0 2 
        Unemployed 8 (73%) 3 1 
        Housewife 1 (9%) 1 0 
    Living    
       Rent 7 (64%) 3 3 
       Own 2 (18%) 1 0 
       Staying with family 2 (18%) 0 1 
   Highest Qualification    
       GCSE/O-level 9 (82%) 4 3 
       A-Level 2 (18%) 0 1 
 





   Schizophrenia 7 (64%) 1 2 
   Schizoaffective Disorder 1 (9%) 1 0 
Bipolar Affective Disorder 3 (%) 2 2 
 
Main Substance in last 30 days    
  Cannabis 8 (73%) 4 1 
  Alcohol 2 (18%) 0 2 
  Cocaine Powder or Crack 
Cocaine 1* (9%) 0 1 




Table 4: Substance use characteristics of in-patients who met the study criteria and consented to 
participate (N=11) 
 
Main Substance in 
last 30 days 





Case 1: MD Cannabis 16 1/8 oz. Daily use 
Case 2: HL Cannabis 15 £10 5 days a week 
Case 3: EB Alcohol 13 
5 pints strong 
lager 3 days a week 
Case 4: XF Cannabis 14 
1 gram/7 
‘joints’ Daily use 
Case 5: NJ 
Poly use- Crack 
cocaine/Heroin 18  £20/£25                          Daily use 
Case 6: LH Cannabis 11 1 ‘joint’ Daily use 
Case 7: GC Cannabis 16 ½ ‘joint’ 4 days a week 
Case 8: KB Cannabis 15 £80/1/2oz Daily use 
Case 9: MR Alcohol 10 1 bottle of wine Daily use 
Case 10:SH Cannabis 23 7-8 ‘joints’daily Daily use 










Time points N (%) 
BL1 BL2 I1 I2 I3 I4 Post 
Follow-
up 
         
Motivation         














(27) 8 (72) 














(27) 8 (72) 















(27) 8 (72) 
Engagement         















(27) 8 (72) 
Insight into Mental 
Health         














(27) 8 (72) 
Note: BL1 = first baseline assessment; BL2 = second baseline assessment; l1-I4 = Intervention time points. 
 
The study aimed to explore if a brief intervention could affect positive change in the psychological 
processes of insight, subjective importance to change substance use and subjective confidence to 
change substance use.  The study also aimed to monitor change in outcomes such as readiness to 
change and engagement with treatment and assess the feasibility of undertaking a brief intervention 









Case 1: MD ‘Bipolar Affective Disorder and regular cannabis use’ 
Pre-Intervention characteristics 
Personal detail 
MD was a 59 year old single white British male.  He reported being educated up to GCSE 
level.  At the time of admission he was retired, living alone and renting his own home.  Before 
retirement he had worked as a long distance lorry driver.  MD reported a close and caring 
relationship with his mother and elder brother. 
Substance use history 
MD reported past use of illicit drugs but no problematic alcohol use. At the time of 
assessment he had been abstinent from alcohol for many years.  MD’s main drug of choice 
was cannabis that he was using on a daily basis (typically 1/8 oz. per day). 
Mental health history 
MD had a diagnosis of Bipolar Affective Disorder (BPAD) and had the diagnosis for 
approximately the last fifteen years.  He had experienced multiple in-patient admissions and 
his current admission was the second in the last 12 months.  At the time of assessment he was 
being held on an acute ward under section three of the mental health act (Mental Health Act, 
2007).  Prior to his admission MD had been regularly engaged with his community mental 
health team (CMHT). 
Routine Care  
As part of his routine treatment MD received psychotropic medication for Bipolar Affective 
Disorder He was generally compliant with medication and routinely attended and actively 
contributed to psychiatric reviews. He also received time limited occupational therapy 
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involvement aimed at improving his activities of daily living and his involvement in leisure 
activities.  
Orientation toward change 
MD reported neither seeking nor being offered SUDs treatment in the six months prior to 
admission.  MD reported that he had no thoughts about changing his substance use in that 
time and was “happy” with the way things were. Case note review, information from the in-
patient clinical team, his SATS score (1, pre-engagement) and disclosure at interview was 
consistent with a pre-contemplation stage of change (Prochaska and DiClemente, 1992). 
Stability during non-intervention period 
MD evidenced stable RTC scores over the baseline period (Ambivalence
B1
 = 8, 
Ambivalence
B2
=7, RCI = -0.34, p = 0.74; Recognition
B1
 = 9, Recognition
B2
=7, RCI = 0.59, p 
= 0.55; Taking Steps
B1
 = 13, Taking Steps
B2
=14, RCI = 0.25, p =0.80). With respect to insight 
into mental health, MD demonstrated stable scores over the baseline period (Insight
B1
 = 2, 
Insight
B2
=1, RCI = -0.53, p = 0.59).  MD’s engagement with drug treatment (as measured by 
the SATS) showed stable scores over the baseline period (SATs
B1
 = 1, Sats
B2
=1, RCI = 0, 
p>0.99). Finally, the severity of substance use evidenced stable scores over the baseline period 
(SDS
B1
 = 3, SDS
B2
=2, RCI = -0.51, p = 0.61) 
Therefore all of the outcome and process variables measured over MD’s baseline assessment 
period were stable. 
Delivery and Content of Intervention 
Participation and Focus of Intervention 
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MD attended all four of the intervention sessions (20-25 minutes each over a 13 day period) 
and engaged with the therapeutic sessions. The intervention focused on providing information 
and eliciting any contemplation or self-motivational statements from MD.  This was done 
through personalised feedback of the results of his assessment, discussion with MD about his 
views about his substance use and the impact on his mental health, the provision of psycho 
educational information on the subject and exploration of the costs and benefits of MD’s 
cannabis use through the use of a decisional balance.  During the intervention it became clear 
that MD had questioned his cannabis use some years ago (“I did wonder...stopped it for a bit 
but it made no difference”) but did not currently find it an issue.  He had positive beliefs about 
cannabis that reinforced his use like it being “the one enjoyable thing I have in my life” and 
“It helps me relax”.  Other maintaining thoughts such as “some people can’t take 
it....shouldn’t take it.....it messes them up but not me” indicated that although MD could 
identify that cannabis could be harmful to some it was not to him (as he had ‘tested it’ before).  
The intervention did not elicit any self-motivational statements of concern or intent to change 
his cannabis use.  He made the decision he would not stop doing something he liked.   
Outcome of Intervention 
Readiness to change scores 
Prior to the intervention MD presented at B2 with “Readiness to change” scores for 
recognition, ambivalence and taking steps of 7, 7 and 14 respectively.  All sub-scores showed 
stability over the baseline period. By the completion of the intervention MD’s RTC scores 
increased by 4 points to 11 for recognition, (RCI = 1.19; p = 0.23), 2 points to 9 for 
ambivalence, (RCI = 0.67; p =0.50) and 9 points to 23 for taking steps, (RCI = 2.28; p =0.02). 
With respect to change over the intervention period, when recalculating the RCI to control for 
trend in baseline period the change over the intervention period was not reliable for 
82 
 
recognition (RCI =1.78; p=0.07) but was for ambivalence (RCI =1.01; p=0.31) and taking 
steps (RCI =2.02; p=0.04).  
Insight  
MD’s pre-intervention score for Insight into mental health was 1 and remained stable across 
the baseline period. After the therapeutic intervention MD’s score had only increased by 1 
point to a score of 2 (RCI =0.53; p=0.59).  This remained the same after variation in the 
baseline was controlled for (RCI =1.06; p=0.29), indicating that the lack of change over the 
intervention period was reliable.  
Engagement  
Engagement with drug treatment did not change over the baseline period, which remained 
stable following the therapeutic intervention (RCI=0, p=>0.99). 
Severity of substance use. 
Before the intervention began MD’s SDS remained stable.  Following the end of the 
intervention MD’s SDS score was unchanged with a score of 2, (RCI=0, p=>0.99). When the 
slight variation over the baseline period was controlled for (RCI=-0.51, p=0.61)  there was no 
discernible intervention effect. 
Frequency and intensity of substance use 
MD remained in hospital throughout the intervention and follow-up period.  He reported 
intent to continue his pattern of use once discharged.  Whilst on the ward he reported using 
cannabis opportunistically on approximately three occasions.  He reported this occurring once 




MD showed no change with respect to the outcomes of ambivalence in RTC, insight, 
engagement or severity of substance use.     A statistically significant increase for taking steps 
and recognition (RTC) was found.  Although ambivalence remained low, as recognition 
increased, this would indicate a significant improvement in RTC.  This is contradicted by 














Case 2: GC ‘Schizophrenia and regular cannabis and alcohol use’ 
Pre-Intervention characteristics 
Personal detail 
GC was a 26 year old single white British male.  He reported being educated up to GCSE 
level.  Prior to admission GC was unemployed and living alone in rented accommodation.   
Substance use history 
GC main drug of choice was cannabis and he reported using a small amount 4 times a week 
(1/4 to ½ a cannabis joint).  Alcohol use was thrice weekly and typically half a bottle of vodka 
or two cans of super strength lager.  GC reported past use of cocaine, crack, heroin, ecstasy 
and magic mushrooms between the ages of 16-21.  He also reported occasions of alcohol and 
cannabis use whilst on the ward. 
Mental health history 
Three years prior to his current admission GC was diagnosed with Schizophrenia.  GC had 
experienced previous admissions to his current section three of the mental health act (Mental 
Health Act, 2007).  The current admission was the first this year.  Prior to admission GC had 
been engaged with his community mental health nurse (CPN) within the community.  He was 
compliant with medication when seen but his contact had become sporadic in the two months 
preceding his admission. 
Routine Care  
As part of treatment as usual GC received psychotropic mediation for Schizophrenia. He 
became compliant with psychotropic medication whilst on the ward and attended weekly 
psychiatric reviews. He also received time limited weekly occupational therapy involvement 
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on the ward aimed at increasing his involvement in meaningful activities such as cookery and 
leisure groups.  
Orientation toward change 
In the six months before the current admission GC reported he had not personally sought or 
received treatment for his substance use.  He did report his care coordinator telling him to stop 
smoking but thought they were “trying to rule me”.  Case note review, feedback from the 
clinical team, SATS score (1. Pre-engagement) and disclosure at interview was consistent 
with a pre-contemplation stage of change (Prochaska and DiClemente, 1992). 
Stability during non-intervention period 
GC’s RTC scores over the baseline period proved to be variable for some of the RTC 
subscales (Ambivalence
B1
 = 10, Ambivalence
B2
=16, RCI = 2.01, p = 0.04; Recognition
B1
 = 18, 
Recognition
B2
=22; RCI = 1.19, p = 0.23; Taking Steps
B1
 = 31, Taking Steps
B2
=39, RCI = 2.02, 
p = 0.04).  Baseline scores for Insight into mental health demonstrated stability (Insight
B1
 = 8, 
Insight
B2
=7, RCI = -0.53, p = 0.59). GC’s engagement with drug treatment (as measured by 
the SATS) showed stable scores over the baseline period (SATs
B1
 = 1, Sats
B2
=1, RCI = 0, 
p>0.99). With regards to severity of substance use GC evidenced stable scores over the 
baseline period (Audit
 B1
 = 10, Audit
B2
=13, RCI = 0.81, p = 0.42; SDS
B1
 = 9, SDS
B2
=8, RCI = 
-0.51, p = 0.61) 
In summary most of the constructs measured over GC’s did not show significant or clinically 
meaningful change over the baseline period with the exception of the RTC subscales of 




Delivery and Content of Intervention 
Participation and Focus of Intervention 
GC attended all four of the intervention sessions (20 minutes each over 12 days) and engaged 
with the therapeutic sessions. The intervention focus included feedback and provision of 
information, identifying any contemplation and eliciting self-motivational change statements.  
Intervention with GC included personalised feedback of his assessment, the provision of 
psycho-educational information and exploration of any maintaining beliefs GC may have 
about cannabis.  He reported that ‘being stressed’ made him want to smoke cannabis which in 
turn helped him relax and it was also used by those he associated with when in the 
community. GC held beliefs about cannabis, such as ‘herbal’ cannabis being harmless and 
healthy in comparison to ‘Skunk’ which “can change your thinking and personality”.   
However he did correctly identify ‘Skunk’ as being a stronger, more harmful type of cannabis.  
Despite GC holding some positive beliefs about cannabis’ having beneficial effects on him he 
also made some statements of concern about the impact on his mental and physical health 
(e.g. “cannabis can make me paranoid......make you hallucinate”).   After eliciting some 
motivational statements about modifying his cannabis use (e.g. “I’m not sure I want to smoke 
no more” and “I don’t want to drink too much” this led to the next phase of intervention.  This 
was development of a change plan, which was anchored by two personal goals (going to the 
gym and refusing cannabis from friends) and exploring social networks that may support or 
hinder these personal goals was also discussed. 
Outcome of Intervention 
Readiness to change scores 
Prior to the intervention GC presented with “Readiness to change” scores at B2 for 
recognition, ambivalence and taking steps of 22, 16 and 39 respectively.  All sub-scores 
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showed variability over the baseline period. By the completion of the intervention GC’s 
“Readiness to change” scores decreased by 6 points to 16 for recognition, (RCI = -1.78; p 
=0.07), decreased 7 points to 9 for ambivalence, (RCI = -2.35; p =0.02) and decreased 7 
points to 32 for taking steps, (RCI = -1.77; p = 0.08).  
Once repeat RCI calculations were undertaken, controlling for variation in baseline measures, 
the original indication of  a significant decrease after the intervention period proved to be 
reliable for ambivalence (RCI =-4.36; p=0.00)., recognition (RCI =-2.97; p=0.00),  and taking 
steps (RCI =-3.79; p=0.00).  Statistical significance of these results was found for all three 
subscales. 
Insight 
GC’s pre-intervention score for Insight into mental health was 7 and remained stable across 
the baseline period. After the therapeutic intervention GC’s score had decreased by 1 point to 
a score of 6 (RCI =-0.53; p=0.59).  RCI increased slightly after variation in the baseline was 
controlled for (RCI =0; p>0.99), indicating that the lack of change over the intervention period 
was reliable in the unadjusted scores.  
Engagement 
Engagement with drug treatment did not change between the beginning of the baseline period 
and follow-up after the intervention period (RCI=0, p=>0.99). 
Severity of substance use. 
Before the intervention began GC’s severity of substance use remained stable.  Following the 
end of the intervention GC’s SDS score remained unchanged with a score of 8, (RCI=0, 
p=>0.99). When the slight variation over the baseline period was controlled for the initial 
result was found to be consistent (RCI=-0.51, p=0.61), still indicating no change.  GC’s 
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AUDIT  score showed stability across the baseline period and his pre-intervention score of 13  
decreased by 5 points to 8 following the end of the intervention (RCI = -1.35, p = 0.18) 
indicating a clinically meaningful decrease.  The adjusted RCI score for the AUDIT supported 
this trend and indicated that the decrease was significant (RCI=-2.15, p=0.03). 
Frequency and intensity of substance use 
Following the intervention assessment GC reported abstinence from cannabis use.  At follow-
up GC reported not using cannabis in the past 30 days but had replaced this with once weekly 
use of a legal high called ‘spell weaver’  (Methiopropamine – a stimulant  ‘legal high’) 
because it made him “feel happy”.  He did not see this as a drug “because it’s legal”.   
Summary 
GC’s scores indicated a statistically significant decrease in all three subscales of readiness 
to change and the AUDIT.  GC showed no clinically meaningful or significant change with 
respect to the other variables measured.  However subjective ratings of importance and 










Case 3: KB ‘Bipolar Affective Disorder and regular cannabis use’ 
Pre-Intervention characteristics 
Personal detail 
KB was a 29 year old Asian British female with a diagnosis of Bipolar Affective Disorder 
(BPAD).  KB was a mother of two young children and at the time of assessment pregnant with 
her third child.  Before admission KB was living with her children in rented accommodation.   
Substance use history 
KB stated that she smoked ‘one spliff' after another before coming into hospital’.  Her main 
drug of choice was cannabis which she smoked heavily on a daily basis (£80/1/2oz).  She 
reported past use of cocaine (once at 25 years old) and alcohol but she reported not drinking in 
the last two years.  On enquiry, she reported her previous alcohol use as ‘something that used 
to get out of control’ and she stopped because of this.  
Mental health history 
KB had a diagnosis of Bipolar Affective Disorder (BPAD).  KB was diagnosed approximately 
6 years prior to her engagement in the present study and had experienced previous in-patient 
admissions.  The last admission was 4 years before her current admission.  KB was held on an 
acute ward under section two of the mental health act (Mental Health Act, 2007) and was 
admitted whilst 8 months pregnant.  Prior to her compulsory admission KB’s local assertive 
outreach team (AOT) had made increasing attempts to engage her in treatment unsuccessfully.  
This lack of engagement, her lack of medication adherence and the risk associated with being 
pregnant led to her admission. 
Routine Care  
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Because KB was in the final stages of pregnancy TAU included a modified medication regime 
for BPAD and prenatal care in regards to her pregnancy.  She was generally compliant with 
psychotropic medication whilst on the ward.  She attended and contributed to psychiatric 
reviews.  Once KB’s baby was born she was transferred to the mother and baby unit with her 
child where treatment with parenting facilities and clinicians specialising in the care of post 
natal patients was available.   
Orientation toward change 
KB had engaged in no treatment with SUDs services for her cannabis use despite reportedly 
being offered an integrated mental health and SUDs intervention by her CPN. Because she 
was pregnant and using substance social services were involved in her care as well as mental 
health services.   Case note review, clinician feedback, SATS scores and disclosure at 
interview are consistent with a contemplation stage of change (Prochaska and DiClemente, 
1992) post admission. 
Stability during non-intervention period 





=19, RCI = 1.01, p = 0.31 and Taking Steps
B1
 = 40, Taking Steps
B2
=39, 
RCI = -0.25, p = 0.80) but variable scores for recognition in RTC (Recognition1 = 35, 
Recognition
B2
=24, RCI = -3.27, p = 0.00). With respect to insight into mental health, KB 
demonstrated stable scores over the baseline period (Insight
B1
 = 11, Insight
B2
=8, RCI = -1.60, 
p = 0.11).  KB’s scores for engagement with drug treatment (as measured by the SATS) 
showed stability over the baseline period (SATs
B1
 = 1, Sats
B2
=1, RCI = 0, p>0.99). Severity of 
substance use scores over the baseline period proved to be stable (SDS
B1
 = 10, SDS
B2
=12, 
RCI = 1.02, p = 0.31) 
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Most of KB’s outcome and process variable that were measured over the baseline assessment 
period were stable except the recognition subscale of RTC.  These two measures indicated 
significant decrease over the baseline period. 
Delivery and Content of Intervention 
Participation and Focus of Intervention 
KB attended 50% of intervention sessions.  Once she had given birth, following the baseline 
phase, her childcare commitment took precedence over participation.  However KB reported 
that she still wished to continue and engaged in two of the four therapeutic sessions. The two 
sessions over eight days each lasted 15-20 minutes.  The intervention focused on feedback, 
information and eliciting self-motivational statements of change.  KB was offered 
personalised feedback of the results of her assessment.  This then led to discussions about 
KB’s use and the impact on her mental health.  KB seemed to acknowledge the impact 
cannabis had on her mental wellbeing and her children’s welfare.  She asked questions about 
cannabis use in pregnancy.  Psycho-educational information was provided and her decisional 
balance tipped towards change.  KB made self-motivational statements about the need to stop 
cannabis use on discharge “for my children”.  Costs and benefits were explored but KB stated 
many more negatives of cannabis use and reaffirmed her strong desire to be abstinent from 
cannabis.  Before the intervention could continue to the next stage for the decision making 
stage of change (change plan and exploration of social support) completing subsequent 
sessions became difficult.  KB was unable to commit to further sessions and then was 
discharged from the unit.   
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Outcome of Intervention 
Readiness to change scores 
At baseline (B2) KB’s RTC scores for recognition, ambivalence and taking steps were 24, 
19 and 39 respectively.  All sub-scores showed stability over the baseline period. By the 
completion of the intervention KB’s “Readiness to change” scores decreased by 5 points to 
19 for recognition, (RCI = -1.49; p = 0.14), decreased 7 points to 12 for ambivalence, (RCI 
= -2.35; p = 0.02) and increased 1 point to 40 for taking steps, (RCI = 0.25; p =0.80). 
Readjustment of the RCI calculation with respect to the trend in baseline measurement 
indicated that the suggested change over the intervention period was reliable for taking 
steps (RCI =0.51; p=0.61) where the indication of no change remained and ambivalence 
which still indicated a significant decrease (RCI =-3.36; p=0.00).  Once adjusted, RCI 
scores for recognition remained non-significant but reversed from a non significant 
decrease to a clinically meaningful increase (RCI =1.78; p=0.07). 
Insight 
KB’s pre-intervention score for Insight into mental health was 8 and remained stable 
across the baseline period. After the therapeutic intervention KB’s score had increased by 
4 points to a score of 12 (RCI =2.13; p=0.03).  Controlling for variation in the baseline 
indicated this indication of statistically significant increase was reliable (RCI =3.73; 
p=0.00). 
Engagement 
KB’s scores for engagement with drug treatment remained stable across the baseline 
period.  By the end of the intervention KB’s score significantly increased by 4 points to a 
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post intervention score of 5, (RCI=10.78, p=0.00). As scores were exactly the same over 
the baseline period no adjustment for variance was needed. 
Severity of substance use. 
Before the intervention began KB’s severity of drug use remained stable.  Following the 
end of the intervention KB’s score decreased by 3 points from 12 in the baseline period to 
9 after the intervention, (RCI=-1.52 p=0.13). When the variation over the baseline period 
was controlled for, the clinically meaningful decrease remained and was statistically 
significant (RCI=-2.54 p=0.01). 
Summary 
KB showed no change for taking steps in regards to RTC but did have a statistically 
significant decrease in severity of substance use.  With respect to putative factors affecting 
the efficacy of the intervention, KB’s scores for insight and engagement significantly 
increased, indicating a statistically significant improvement in these constructs.  The 
indicated meaningful increase in recognition (RTC) must be viewed with caution due to 
the large baseline variation.  Despite an increase in recognition the post intervention score 
remained low.  In contrast to this KB reported abstinence at follow-up and high confidence 








Case 4: SH ‘Schizoaffective Disorder and regular cannabis and alcohol use’ 
Pre-Intervention characteristics 
Personal detail 
SH was a 50 year old divorced black British male.  He reported being unemployed prior to 
admission but was previously self-employed.  SH reported being educated to GCSE level and 
lived alone in his own home. 
Substance use history 
SH’s typically smoked cannabis, his drug of choice at home and reported smoking up to eight 
cannabis joints on a typical day.  SH reported using cannabis as a stress reliever.  It began as 
occasional use when he was younger and increased over time.  He reported also using alcohol 
twice weekly (typically half a bottle of brandy).   SH did not see his drinking as a problem.  
On further inquiry SH reported spending a lot of money on drink and always having it in the 
house in ‘case I need it’.  He also reflected upon his family history of alcohol use, reporting 
‘my father’s side were said to be drunkards’.   
Mental health history 
SH had a diagnosis of schizoaffective disorder and had been diagnosed approximately 22 
years previously.  SH was held on a psychiatric intensive care unit (PICU) under section three 
of the mental health act (Mental Health Act, 2007).  He had experienced multiple in-patient 
admissions since his early 20’s.  KB had previously been treated for depression.  KB’s 
engagement with his local AOT prior to admission had been very erratic and in the weeks 




Routine Care  
As part of TAU, SH received psychotropic mediation for schizoaffective disorder. Whilst 
admitted he became more compliant with psychotropic medication but did not readily engage 
with psychiatric reviews. Towards the end of admission SH undertook time limited 
occupational therapy aimed at improving his engagement with others via leisure activities. 
During the intervention SH was moved from the PICU to an acute ward.  At the point of 
follow-up he had moved to another acute ward.  TAU continued throughout and was only 
halted when SH absconded for one week.  Treatment resumed on his return. 
Orientation toward change 
SH reported that he was unsure if his cannabis use was a problem but resented others telling 
him it was.  Case note review, SATS score, disclosure at interview was consistent with a pre-
contemplation stage of change (Prochaska and Diclemente).  SH’s CPN did ask about his drug 
use and offered him SUDs  intervention with a  drugs worker ‘once or twice’ in the last six 
months but SH felt that he didn’t see there was a  problem as others did at that time 
Stability during non-intervention period 
SH scores for RTC over the baseline period indicated stability for ambivalence 
(Ambivalence
B1
 = 18, Ambivalence
2
=18, RCI = 0, p = 1.00) but not the remaining subscales 
of RTC (Recognition
B1
 = 23, Recognition
2
=16, RCI = -2.08, p = 0.04; Taking Steps
B1
 = 26 
Taking Steps
B2
=34, RCI = 2.02, p =0.04).  Insight into mental health scores demonstrated 
stable scores over the baseline period (Insight
B1
 = 7.5, Insight
B2
=6, RCI = -0.80, p = 0.42).   
With respect to SH’s engagement with drug treatment his scores evidenced stability over the 
baseline period (SATs
B1
 = 1, Sats
B2
=1, RCI = 0, p>0.99). Finally, the severity of substance use 
evidenced stable scores over the baseline period for severity of drug use (SDS
B1





RCI = -0.51, p = 0.61) but highly variable scores for Alcohol use (Audit
 B1
 = 23, Audit
B2
=14, 
RCI = -2.42, p = 0.02) 
In summary insight and engagement scores were stable for SH.  With regards to RTC 
ambivalence was a stable subscale but recognition and taking steps were variable.  For 
severity of substance use, drug use scores were stable but alcohol use scores were highly 
variable. 
Delivery and Content of Intervention 
Participation and Focus of Intervention 
SH attend all four of the intervention sessions (approximately 20 minutes each over 15 days) 
and engaged with the therapeutic process. The intervention focused on offering personalised 
feedback of the results of SH’s assessment, psycho-educational information about cannabis 
and the potential impact on mental health and elicit SH’s beliefs about his use and changing 
his cannabis use.  In exploring SH’s reflections on the information shared some maintaining 
belief and cycles of use were elicited.  SH had beliefs about cannabis relieving his distress and 
reported use as a way to self-medicate.  Although he reported most of his family did not like 
him smoking he engaged in cannabis use with one of his older siblings.  He mentioned his 
mother, as well as those involved in his clinical care being concerned about his cannabis use. 
He admitted that his perspective on the situation ‘changes by the day and my mood’.  A 
decisional balance was undertaken and although produced many positive beliefs about his 
cannabis and alcohol use he also produced many negatives such as feeling like his physical 
health was being affected, getting into near miss serious accidents when under the influence 
and “maybe it escalates my symptoms when I am thinking negatively”.   Half way through the 
intervention time points SH reported self-motivational statements about changing his drug use 
such as reducing his cannabis use being important to his physical and mental health.  He also 
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noted that he was increasingly aware of how his use affected others (i.e. his mother and some 
of his siblings). The last focus of the intervention included beginning a change plan and the 
facilitative nature of positive social networks in the change process. 
Outcome of Intervention 
Readiness to change scores 
At baseline (B2) SH presented with “Readiness to change” scores for recognition, 
ambivalence and taking steps of 16, 18 and 34 respectively.  The ambivalent sub-score 
showed stability over the baseline period but other subscales did not. By the completion of the 
intervention SH’s “Readiness to change” scores decreased by 2 points to 14 for recognition, 
(RCI = -0.59; p = 0.55), decreased by 10 points to 8 for ambivalence, (RCI = -3.36; p =0.00) 
and 3 points to 31 for taking steps, (RCI = -0.76; p= 0.45).  Adjusted secondary RCI scores 
suggested the indication of no meaningful or significant change remained for recognition (RCI 
=1.49; p=0.14) but not for taking steps (RCI = -2.78; p= 0.01). As there was no baseline 
variation in SH’s ambivalence sub-score there was no adjustment to be made. 
Insight 
SH’s pre-intervention score for Insight into mental health was 6 and remained stable across 
the baseline period. After the therapeutic intervention SH’s score had decreased by 1 point to 
a score of 5 (RCI =-0.53; p=0.59).  This indication of no change was reliable and remained 
once the RCI was calculated to allow for the trend in the baseline score (RCI= 0.27; p=0.79).  
Engagement 
Engagement with drug treatment did not change and remained stable over the intervention 
period.  SH’s score remained unchanged after the intervention ended. 
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Severity of substance use 
Before the intervention began SH’s severity of drug use remained stable.  Following the end 
of the intervention SH’s SDS score decreased slightly by 1 point from a score of 4 to 3, 
(RCI=-0.51, p=0.61). When the slight variation over the baseline period was controlled for the 
finding of no change was found to be reliable (RCI=0, p=>0.99). For Alcohol, SH’s scores 
over the baseline period were highly variable.  SH’s pre-intervention score of 14 decreased by 
4 points to 10 following the end of the intervention (RCI=-1.08, p=0.28).  Adjustment, taking 
the high variation in the baseline period into account, indicated the original RCI for the Audit, 
despite changing direction, continued to show no change (RCI=1.35, p=0.179). 
Summary 
SH showed no statistically significant or clinically meaningful change for insight, engagement 
or severity of drug use.   With respect to changes after the intervention for alcohol use SH’s 
decreased AUDIT score did not infer a clinically meaningful or statistically significant 
improvement in severity and intensity of alcohol use. With regards to RTC ambivalence 
scores indicated a significant decrease in this subscale.  Although adjusted scores indicated a 
statistically significant reduction in taking steps the baseline variation was large enough to 







Clients not receiving an intervention   
The following section presents the results for baseline stability and any indications of reliable 
change for the four clients who did not receive the intervention.  Further information on the pre-
intervention characteristics of the non-intervention clients can be found in appendix 14.  
Stability during non-intervention period 
NJ was only assessed once over the baseline period due to early discharge.  For the remaining 
three non-intervention cases all three subscales of the RTC were stable over the baseline 
period. Insight into mental health scores demonstrated variable scores over the baseline period 
for HL and MR.  Engagement and severity of substance use scores were all stable. Please see 
appendix 15 for all baseline RCI scores for non-intervention cases. 
Outcome of Intervention 
Readiness to change 
At follow-up all of the RCI scores (please see appendix 15 for all scores) for the non-
intervention cases indicated no statistical or clinical significance (RCI’s all under 1.96 and 
non-significant) for all of the RTC subscales with the exception of a statistically significant 
decrease in ambivalence (RCI=-3.02; p=0.00) for HL. 
Insight 
No meaningful change was indicated for insight scores for any of the non-intervention  cases. 
Engagement 
Engagement scores remained at 1 (pre-engagement) throughout time points for all non-
intervention cases except NJ.  Her baseline score increased significantly (RCI= 2.69; p=0.007) 
100 
 
Severity of substance use 
SDS scores decreased significantly between the baseline and follow-up period for HL’s 
(RCI=-3.55; p=0.00) and EB’s (RCI=3.05; p=0.00) SDS scores.  NJ and MR’s SDS score did 
not indicate any meaningful change.  Audit scores remained unchanged for MR but decreased 
significantly for HL and EB (RCI=-7.80, p=0.00, RCI=-4.36, p=0.00). NJ was teetotal. 
Importance and confidence to change substance misuse 
A ceiling effect was observed for HL who rated 10/10 throughout. EB, NJ and MR all 
reported increased ratings of importance at follow-up.  With respect to subjective ratings of 
confidence to change substance use ceiling effects were observed for HL again.  The 
remaining 3 non-intervention cases all reported some increase in subjective confidence at 
follow-up.   
Frequency and intensity of substance use 
HL reported abstinence from his drug of choice, cannabis, at follow-up.  MR reported 
drinking at the same levels as when measured at baseline.  NJ reported a small reduction in 
her heroin use (£5) but was still using the same levels of crack and using both substances daily.  
Although he drank similar amounts on a drinking day EB reported a reduction in number of 
drinking days.  He had drunk three times since his discharge from hospital. 
Summary 
Most RCI scores for non-intervention cases were not found to indicate any clinically 
meaningful or statistically significant change in regards to RTC, insight or engagement. . 
There were a few exceptions in regards to HL’s decrease in ambivalence and NJ’s improving 
engagement.  However with respect to severity of substance use and levels of use, there was a 
marked reduction for three of the four non-intervention cases. 
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Comparison of intervention and non-intervention clients 
The following figures (3-10) on pages 102 to 107 depict the pre assessment measure (B2) scores 
and post intervention measures of readiness to change, insight, engagement, severity of use, 
importance and confidence to change substance misuse for both intervention and non-intervention 
cases in order to compare similarities or differences between the two groups of clients.   The red 
circles represent cases that undertook the intervention and the black crosses represent the non-
intervention cases. The solid black line represents the line of no change.  The dashed line 
represents the line of clinically meaningful change and the dotted line represents the line of 
significant change. Hence any cases on the following graphs lying outside of the dashed or dotted 












Figure 3: Scatter plots showing pre and post intervention scores for the outcome measure Stages 
of change and treatment eagerness (SOCRATES) 
 
 
Figure 3 shows that more intervention cases have a statistically significant change in scores for  
recognition scores after intervention compared to non-intervention cases.  More of the non-
intervention cases lie within the clinically meaningful area.  The figure shows all but one of the 
intervention cases has significantly reduced ambivalence compared with the non-intervention cases 
whose results vary.  For the taking steps subscale no difference is observed in the spread between 
the two groups. 
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Figure 4: Cartesian graph showing the relationship between ambivalence and recognition scores on the 




As highlighted in table 1 in the methods section the meaning of ambivalence scores for readiness to 
change is understood and interpreted in relation to recognition scores for readiness to change.  The 
graph in figure 4 above displays the four relationships between ambivalence and recognition.  
Sector A represents low ambivalence and high recognition indicative of a readiness to change 
substance use.  Sector B represents high ambivalence and high recognition, indicative of awareness 
that change is needed but an uncertainty about taking action.  Sector C represents low ambivalence 
and low recognition and sector D represents high ambivalence and low recognition. Both sector C 
and Dare indicative of low readiness to change. 
The graph shows the majority of intervention and non-intervention cases have low ambivalence 























of the cases’ (e.g. GC) scores, compared with their baseline scores, have improved overall 
readiness to change. 





     
 
Figure 5 is indicative of a variance in scores across both groups with most cases lying within the 
area of no change. 
 
                                                          
1
 For cases with similar scores the data points in the graphs in figure 5 overlap. 
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Figure 6: Scatter plots showing pre and post intervention scores for the outcome measure 
substance abuse treatment (SATs).
2
 
                                       
Figure 6 illustrates a cluster of intervention and non-intervention cases who remained, both pre and 
post intervention, at the initial stage (1, pre-engagement) of the SATS.  A significant increase was 
found for one intervention (KB) and one none intervention case (NJ). 
Figure 7: Scatter plots showing pre and post intervention scores for the outcome measure severity 
of dependence (SDS) 
                               
                                                          
2
 In figure 6 a majority of the cases overlap due to similar pre and post intervention scores. 
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SDS scores (figure 7) show most of the cases lying within the range of no change with comparison 
to the non intervention cases. One of the cases (KB) and 2 of the non-intervention cases showed 
some meaningful reduction in SDS scores. 
Figure 8: Scatter plots showing pre and post intervention scores for the outcome measure for the 
Alcohol use disorders identification test (AUDIT). 
                     
For those cases who reported drinking alcohol, bar one non-intervention case (MR), both non-
intervention and intervention cases showed a clear improvement (reduction in AUDIT scores post 


































Figure 9: Scatter plots showing pre and post intervention scores for the process measure of 
importance to change substance use
3
 
                         
Subjective scores on the importance ruler (figure 9) displayed no clear differences between the two 
samples.  Most cases lay within or on the border of no change. 
Figure 10: Scatter plots showing pre and post intervention scores for the process measure of 
confidence to change substance misuse
4
 
                          
Ceiling and floor effects for some cases and controls were observed.  No distinct patterns of 
meaningful change were found in the intervention compared to the non-intervention cases. 
                                                          
3
 In figure 9 HL and KB’s high scores overlap.   
4
 In figure 10 a majority of case data points overlap due to similarly high ratings. 






























































Post Intervention interviews 
The three participants who completed the complete intervention (MD, GC and SH) undertook a 
brief semi structured interview when post intervention measures were collected at time point seven.  
The interview provided further insight into the agreeability of a brief intervention to in-patients and 
gathered their views on the experience of participating.  MD enjoyed talking about his experiences 
of SUDs and SMI.  He found it helpful to talk but not necessarily regarding wanting to make a 
change in his use.  GC reported that taking part was ‘good’ and he found it helpful to ‘get 
involved’.  SH reported that he felt the intervention had been ‘respectful’ and it had been ‘alright’ 
taking part.  None of the cases reported anything unhelpful or negative about the intervention.  MD 











Although brief semi-structured interviews were only under taken with a small number of the 
sample the following emergent themes are tentatively discussed and presented below in figure 11. 
Figure 11: Diagrammatical presentation of themes and sub-themes of post intervention interviews  
              
      
       
 
Theme 1: Helpful to talk 
All three participants reported that they had found it beneficial having someone talk to them about 
their SMI and co-existing SUDs. 
Sub-theme A: Listened to  
Two of the three completed cases spoke about being talked at rather than being listened to 
when admitted and valued the opportunity to talk and be listened to. 
          “Being listened to and getting advice and support” –GC 
• Listened to 
• feelings validated 
Helpful to talk  
• Impact of information  





•Reflecting on the impact of 
substance misuse Reflection 







         “You listened……it was respectful”-SH 
 
Sub-theme B: Validated 
Case one felt the intervention gave him the opportunity to talk about his use but he found it 
helpful as a way of confirming the information he already held about cannabis.  He agreed 
it was harmful to some but still held the belief that this was not the case for him. 
“More certain…sure of what I am thinking and what I’m doing”.-MD 
 
Theme 2: Information Provision 
Sub-theme A: Impact of information provision 
Two of the three cases found that the psycho education about the substances they were 
using and the potential impact on their mental health was surprising.  Some discussion in 
the intervention session illustrated that they took some of this new information on board 
demonstrated by their comments. 
“….Shocked when I saw what I was drinking” –GC 
“It opened my eyes to the road I am going down that I don’t really want to go down”-SH 







Sub-theme B: New information 
All three cases appeared interested and motivated to both receive information about their 
substance use and mental health.  In sessions this led to further discussion and questions 
from all three.  The following comments were made: 
“Happy to learn something new”- MD 
“The possibility that something will come up that I’ve not thought through…… but you 
haven’t covered anything that I haven’t already thought through in my head” MD 
“Knowing more about the drugs that I was using and the units”-GC 
“The info session was very helpful “-SH 
Theme 3: Reflection on the impact of their SUDs 
Cases reported that talking about their use made them think about how their use was affecting them 
and others around them (e.g. friends and family) 
“It’s made me reflect on my lifestyle….. how it might be affecting people....the people that might be 
hurting”-SH 
Theme 4: Fear 
Sub-theme A: Talking about self 
The cases spoke about their reluctance to talk about their substance use and mental health 
symptoms with clinical staff.  One case reflected on his general fear of talking about 
difficulties in life. 
On talking about drugs and mental health- “It’s kinda scary at first but good cuz (sic)  I 
don’t normally talk to people about my problems… but I let it out”-GC 
“It’s getting easier to talk about it…its hard”-SH 
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Sub-theme B: Stigma  
“The chance to talk to someone who showed understanding and was non-judgemental so 
that helped”-MD 
“It helped….talked to by a lady. I think men will be more judgemental”-SH 
Suggestions 
In regards to how the intervention could be improved GC suggested that refreshments be offered to 
build rapport and “help users feel welcome”. He also suggested more concrete demonstrations of 
negative representations of substances in order to reinforce their harmful effects. 
“Get a drink, make client smell it and tell them what it’s doing to their gut-cuz it rots. ……With 
cannabis put it in jar and let them smell it when it’s gone off to stop em from smoking it.............”-
GC 
SH suggested the police be utilised to talk to people and “educate patients on wards because drug 
workers don’t always have time to spend on a ward like this”.  He also suggested that the psycho 
education be something that is repeated “because sometimes some people might not get it the first 
time” and “more people should do it”. 
On enquiry about peer support and staff undertaking the intervention all of the cases thought peer 
support would be good. They thought staff would only be good facilitators if they were non-
judgemental.   





To date, there have been no detailed research pilot studies of a brief intervention for patients with 
SMI and co-existing SUDs in an in-patient setting.  The present study used case series 
methodology to explore feasibility whilst examining in depth any impact on processes of insight 
into mental health and importance and confidence to change substance use.  Additionally outcomes 
of engagement and readiness to change (RTC) were evaluated.   
Overall there were few clinically meaningful or statistically significant changes in outcome or 
process variables for both the intervention and non-intervention cases. In contrast to scores on the 
outcome measures, many cases in both groups reported reduced levels of their substance of choice. 
(although not the studies focus). Similarly other studies evaluating BI’s with mental health 
populations with SUDs have found changes in levels of use for both cases and controls (Kaner, 
Brown and Jackson, 2011).  Some of these trials also in in-patient psychiatric settings have been 
replicated in this study (e.g Hulse and Tait, 2002; Martino et al., 2006).  The potential threat to 
internal validity of assessment reactivity in SUDs outcome studies (Kamina, Burleson and Burke, 
2012) and in BIs in particular (e.g Donovan et al., 2012) was contemplated as a possible 
explanation similar outcomes of reduced use between the groups.  Also two of the intervention 
cases were still in-patients at follow-up.  A potential complication when measuring substance use 
following an in-patient admission is the fact that it may become more difficult to access substances 
whilst in an in-patient unit, hence reducing opportunities to use.  
Constructs of readiness to change and engagement perhaps did not show change not only due to the 
small sample size and short follow-up but also because the fluid nature of readiness to change.  
Carey et al (1999) point out that the complex mix of behavioural, cognitive and environmental 
factors make readiness to change a difficult construct to measure.   Interestingly self-reports of 
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reduced levels of use and qualitative responses from participants were more indicative of potential 
shifts in readiness to change. 
Some of the limitations of the study are discussed below. Overall, taking into account both 
quantitative and qualitative findings together, the picture appears to suggest some level of 
therapeutic engagement during the intervention and some exposure to the intervention components. 
Whilst some changes in the key variables measured, both as part of process and outcome were 
observed, the pattern of change did not consistently show movement in the predicted direction. The 
fact that some participants reflected upon the fact that the intervention made them reflect on their 
substance use whilst  limited measurable change was found, may suggest that the brief nature of 
the intervention limits the possible impact and that longer exposure to the intervention components 
may be required in order to show change.  
 
Strengths and methodological limitations 
A strength of this study was the success in engaging clients to discuss their substance misuse and 
lending some support to the study rationale for utilising window of opportunity to engage in-
patients during admission.  The small sample size and problems engaging cases limit to some 
extent the robustness of the conclusions although also reflect issues of feasibility relevant to a 
potential larger study.  Attrition in the baseline sample ‘(at the point of assessment) and the 
subsequent impact on the commencement or continuation of the brief intervention was mainly due 
to discharge from the in-patient unit.  Only one of the eleven participants declined to continue once 
the research began.  Given the time limitations and scope of this pilot study it is estimated that the 
some of the difficulties encountered regarding recruitment, sample retention and attrition to follow-
up could be managed/minimised in a larger experimental design study. 
115 
 
Lessons have been learnt regarding the intervention model.  Although the idea was to have a set 
number of multiple contacts in a brief period (two weeks) for this short burst style BI the reality of 
the variable and unpredictable length of patient stay calls for an even more flexible model of 
intervention than this study attempted.  The in-patient length of stay needs to be taken more into 
account.  Follow-up was planned to be approximately one month post intervention of the follow-up 
but in some cases this took longer.  Follow-up in the community proved to be extremely difficult 
(e.g. contact in the community, appointment success etc.) despite the kind cooperation of 
community psychiatric teams.  This is indicative of service difficulties with engagement.  Along 
with larger numbers, a longer follow-up period (e.g 6-12 months) would offer a more stable 
interpretation of outcomes and clearer indication of the length that the  impact of the BI remains 
for.   This would be achievable in future studies with a larger sample and more resources.  
Another possible limitation of the study was the sensitivity of some of the measures used.  For 
example some clients took action that indicated they were in the action stage of change yet 
responses on the SOCRATES did not reflect this.  Carey, Purnine, Maisto and Carey (1999) 
suggest psychometrics measuring stages of change are often incongruent with the stages of the 
model. Additionally the SATS may not have been the most suitable measure to use at such an early 
time point.  A measure of both mental health and SUDs treatment engagement at one month 
follow-up and the SATS at a later interval may have been more useful.  Other measures of 
engagement such as the service engagement scale (SES) (Tait, 2002) were considered but not 
utilised.   The SES for example only measures community mental health engagement when, for 
this study, some participants may still be in-patients at follow-up.  There may be a need for the 
development of more sensitive measures of engagement and readiness to change more suited this 
population that takes both the in and outpatient setting into account.   
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Clinical Implications and Issues for Implementation 
The challenge of providing integrated treatment in the in-patient setting and brief intervention to be 
feasible and efficacious, for acutely unwell patients before discharge, cannot be underestimated.  
This study built on the efforts that clinical teams make in trying to encourage motivation and 
engagement along the treatment pathway from in-patient treatment to community care.  Crucial to 
making such BI’s more feasible and encouraging engagement in the impatient setting is a clearer 
understanding amongst the multidisciplinary team of client’s substance misusing behaviour (Drake 
et al 2003) and the perpetuating impact of positive beliefs about use. Whilst screening, recruitment 
and patient participation were conducted it was observed that the nature and extent of a patient’s 
substance use was often not identified or was known anecdotally but not incorporated into patients’ 
care plans.  The appropriateness of the treatment as usual offered to patients with non-identified 
SUDs (e.g cannabis use) would be in question..  As noted by Graham and Maslin (2002) in their 
study of cannabis use amongst those with co-existing SMI, the patients use of cannabis can often 
be over or under emphasised in the understanding of a person’s difficulties and what may be 
exacerbating symptoms, engagement and recovery.  Staff knowledge and training along with 
confidence in identifying and raising the issue of substance use with in-patients is absolutely 
crucial to the successful implementation of integrated care with this client group (Drake et al., 
2003), whether this be a BI or another mode of intervention.  
Focused interventions have implications for early intervention, medication, moving on, and length 
between admissions, they should be a core part of care planning.  Staff could make (at least) one 
obligatory attempt to engage identified patients.  The importance of consistently asking patients 
both in acute settings and the community about their desire to utilise support, is especially 
important as contemplation can wax and wane within the same patient.  These few cases 
highlighted some clients at a stage of change appropriate to intervention were not asked, perhaps 
because of previous refusal, if they wanted SUDs intervention.   It is also acknowledged that as 
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mental health symptoms can relapse and remit through illness course (Valliant, 1978); a similar 
pattern could be found in substance use with this population (explanation of change in use over 
short period).  Brief interventions in particular have positive consequences in terms for improving 
cost effective care (Babor et al., 2007; Bien, Miller and Tonigan, 2003) and could contribute 
towards addressing use on in-patient wards.  
Future Research 
As well as acknowledging that more clinical work on fostering motivation is needed in in-patient 
settings, more research needs to be undertaken to underpin the evidence base for this.  More 
research and analysis of socio-demographic variables as predictors of engagement in the studied 
population would assist with targeting the most treatment approach depending on any identified 
differences. 
As previously intimated there is a need to research the impact and feasibility of BI’s for those with 
SMI and Co-existing SUDs in in-patient settings with much larger sample sizes and rigorous 
methodology.  The replication of such studies in order to gain reliable consensus on efficacy is 
needed. 
In England the National Institute for Health Research’s (NIHR) Research for Patient Benefit 
(RfPB) program was established in 2006 with the aim of improving the evidence base for and 
methods of intervention offered to patients.  Following on from, and informed by lessons learnt 
regarding methodology and recruitment from this study, an NIHR RfPB pilot randomised 
controlled trial is being undertaken within the same mental health trust in in-patient mental health 
wards across the city.  The study will recruit a larger sample size (90 participants) and incorporates 
the idea of ward staff facilitation of the intervention plus peer support.  This is a positive step 
towards the necessity for an increase in research for this population in in-patient settings.  
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There is undoubtedly a need for further research on what works and the suitability of BIs with this 




















The present study found the undertaking of a short burst brief integrated motivational intervention 
in an in-patient psychiatric setting for people with SMI and SUDs is feasible but potentially 
complicated.  BI’s in such are setting are made more difficult if they are inflexible and fail to very 
carefully account for the unpredictability of the in-patient milieu and length of stay  A flexible 
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Appendix 1: Public Domain Briefing Document 
This thesis was submitted as partial requirement for the Doctorate in Clinical Psychology at the 
University of Birmingham and consists of two volumes. This public domain briefing summarises 
the two parts that comprise Volume one: A literature review and an empirical paper. 
Literature Review 
Brief interventions for alcohol use both in the community have been widely research.  However 
when it comes to research for in-patient settings which additionally focus on drug use only 
(specifically illicit drugs) only there is a dearth of research. 
The literature review sought to appraise and compare the available research evidence for the 
efficacy of brief intervention for illicit drug use in two acute inpatient hospital settings.  Studies 
were reviewed in these two settings in turn, by outcomes the available research studies have 
measured.  Studies largely focused on reducing the levels of drug use and increasing engagement 
with substance treatment in both settings.  Evidence of the efficacy of brief interventions in 
positively impacting upon these outcomes was variable.  Studies in the emergency department 
reported change in outcomes to a larger degree than studies in inpatient psychiatric settings.  When 
longer follow-ups were focused on findings indicated a lack of consensus for the evidence for the 
efficacy of brief interventions in these settings.  
There is a need for further research incorporating more rigorous methodology and larger sample 
sizes testing homogenous brief interventions. 
Empirical Paper 
Background and Aims: The prevalence co-existing substance misuse (SM) in patients with severe 
mental illness (SMI) is a common occurrence in today’s society (Reiger et a., 1990; Drake et al, 
2003; Kavanagh et al., 2004; Public Health England 2012).   This study sought to test the 
127 
 
feasibility of a brief intervention for clients with coexisting mental health and substance misuse 
difficulties in an in-patient psychiatric setting.  The impact on key psychological processes such as 
importance to change, confidence to change and insight were explored as well as measuring any 
change in important outcomes such as readiness to change and engagement with treatment as 
usual. 
Methods: 11 participants diagnosed with severe mental illness (SMI) and coexisting substance use 
disorder (SUD) were recruited to the study from three in-patient psychiatric wards.  A case series 
design encompassing a pre-intervention baseline assessment period, a brief integrated motivational 
intervention (four 15-30 minute short-burst sessions) and post intervention assessment 
(immediately following the intervention and approximately one month after) was undertaken.  
Eight of the 11 participants were followed up. Four intervention cases and four control non-
intervention cases were analysed for any clinical or significant change in process and outcome 
variables using the reliable change index (RCI) (Jacobson and Traux, 1991) and graphs for visual 
inspection.  Qualitative themes from brief post intervention semi structured- interviews were 
identified and integrated with the quantitative data. 
Results: Of the cases who undertook the complete intervention, all of them were patients whose 
hospital stay spanned the length of the intervention and beyond. This indicated a sufficient level of 
agreeableness to the intervention during the admission period and that the ‘window of opportunity’ 
can be utilised to effectively engage patients in intervention during the in-patient stay in 
preparation for discharge to continued community treatment.  At follow-up the intervention cases 
showed no significant difference in process and outcome variables in comparison to the non-
intervention cases.  Both groups reported little change in process or outcome variables following 
the intervention.  In contrast to this a number of cases from both groups reported reduced use of 
their main substance of choice.  Themes from the post intervention semi-structured interview on 
their views of undertaking the intervention included the intervention being seen as helpful and 
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leading to reflection on the impact of substance use.  Participants also spoke about fear and 
judgement being part of the reluctance to talk about their substance use with clinicians. 
Discussion: This small case series has provided insight into the processes and hurdles of 
evaluating the feasibility and efficacy of undertaking brief interventions in acute mental health in-
patient settings for patents who also have co-existing substance use disorders.  However there is a 
need to continue the attempt to find what works for fostering clients’ readiness to change their 
substance use and engage in clinical care in the community.  The brief integrated motivation 
intervention appeared to be feasible for those patients whose length of stay spanned the 
intervention.  Difficulties in implementation such as attrition of the sample due to discharge and 
follow-up in the community were identified.  Issues for implementation and future research include 
methods for managing sample attrition, training of clinical ward staff to increase clinician 
awareness, assessment skill and intervention planning and implementation.  Additionally the need 
for more sensitive assessment measures for this population and a more flexible method of 
administering the brief integrated motivational intervention taking more account of length of stay 
to aid viability.  Whilst the study results may lack support for the efficacy for using brief 
interventions in in-patient psychiatric settings it highlights issues to be addressed and the need for 
larger sample randomised studies to be conducted to aid the search for a more definitive picture of 
the value of brief interventions in impacting engagement and readiness to change during the 
window of opportunity. An on-going randomised controlled trial has taken the findings from this 
pilot into consideration in the design and execution of a city wide randomised controlled trial 
testing the efficacy of a brief integrated motivational intervention within this setting. 
Conclusion: The window of opportunity with this client group is feasible but requires 
methodological modification and further testing. The efficacy of the use of brief interventions to 
affect change remains unclear and further research is needed to expound on this.
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Appendix 2: Participant information Sheet 
 
 





Participant Information Sheet: 
Testing a Brief intervention on a Mental Health In-Patient Unit. 
 
We would like to invite you to take part in our research study.  If you are interested please 
read this carefully before you decide. You may like to discuss it with your family, friend, 
nurse or mental health advocate.  Your participation is entirely voluntary. Please ask if there 
is anything which is not clear or if you would like more information. 
 
What is the purpose of this study? 
 
We are trying out a new way of talking with service users on in patient units who misuse substances 
(drugs and alcohol). We want to explore what helps people if they want to change their substance 
use. 
 
Why have I been invited? 
 
We are inviting you and other people currently on the unit to ask if you would be interested 
in taking part in this research study.  
 
Do I have to take part? 
 
Participation is completely voluntary, and will not affect any treatment or care you are 
receiving, in any way. If you decide to participate you are still free to withdraw from the 
study at any time, without giving a reason.   
 
What will happen to me if I take part? 
You will be asked to sign a consent form and give contact details (your own address and 
telephone number). The research will last for one month (not including follow-up/or two 
months if follow-up is included?). You will be asked to take part in: 
 
1. An initial session to complete questionnaires and ask some questions about your 
substance use and mental health. 
 
2. Four brief intervention sessions on the unit lasting 15-30 minutes each.  These will be 
spread over two weeks.  These will be with a researcher discussing your beliefs with 
you about your substance use and mental health.  We will discuss with you your 
views about treatment. 
 
3. A session after the intervention sessions to repeat the questionnaires you did at the 
initial session and conduct an interview about your experiences of taking part in the 
intervention.   
 
Dionne Harleston  
School of Psychology   
University of Birmingham,  
Edgbaston,     
Birmingham, 
B15 2TT     
   
 
Tel: 0121 XX XXXX     





4. If you have consented for us to do so; we will contact you and arrange to see you one 
month after you have finished the research to repeat the same questionnaires again.  If 
you are no longer on the unit we can arrange to see you at a time and  
place that is convenient for you.  If you need to travel to us we will reimburse you for 
any travel expenses you may incur. 
 
 
What are the possible disadvantages and risks of taking part? 
 
Some of the questions you will be asked may be sensitive.  If, at any time, you do not wish to 
answer a question or feel uncomfortable about doing so, that is absolutely fine. Just tell the 
researcher you do not want to answer and they will move on to another question. Please feel 
free to leave the room and take a break when you like, or ask the researcher for a break.  
 
 
What are the possible benefits of taking part? 
 
You may find that taking part in the study helps you to think about what affect your 
substance use and mental health have on each other but we don’t know if taking part in the 
study will have any benefit to you personally.  However we hope you will feel it is 
worthwhile, and that your contribution may help to improve the care offered to other people 
in the future.  
 
Will my taking part in the study be kept confidential? 
 
Anything you say during the interview will be treated as completely confidential.  This 
includes discussions we may have about your personal substance use.  The information you 
provide will not be shared with anyone else including staff on the ward, your clinical team 
and your family. The exceptions to this are: 
 Where you reveal that you are currently intending to harm yourself or someone else.  
In this case researcher will have to pass just this specific information onto you 
professionals involved in your care following discussion with yourself.  
 
 Where you give specific details such as names, dates, times and places leading to 
identification of a crime (other than personal drug use) the researcher would have to 
share this with study supervisors. 
 
On any questionnaires or interview paperwork completed you will not be identified by name 
but by a code number and all information obtained from you will be held in this anonymous 
form.    
 
You may wish to discuss your participation in this study and any issues that arise from the 
interview with your general practitioner (GP). If you agree then we will send a letter 
explaining that you have participated in this study and an outline of what the study is about to 
your GP. There is a place on the consent form for you to tell us whether or not you are happy 








What will happen if I don’t want to carry on with the study? 
 
If you decide to participate you are still free to withdraw from the study at any time, without 
giving a reason. Withdrawal from the study will not affect any treatment or care you are 
receiving.   
 
What if there is a problem? 
 
If you decide to take part in the study and have a concern about any aspect of it, please call 
the University of Birmingham and ask to speak with either Alex Copello (0121 414 7414) or 
Hermine Graham (0121 414 7204).  If they are unavailable a message will be given for them 
to call you back as soon as they can.  If you remain unhappy and wish to complain  
formally, you can do this through the NHS Complaints Procedure.  Details can be obtained 
from Patient Advice & Liaison Services (PALS) at (0121 255 0707).   
 
What will happen to the results of the research study? 
 
A summary report of the study findings will be made available to participants in September 
2013 and we are happy to send you a copy if you would like one.  It is hoped that the results 
of the study will be published in a mental health journal and inform the work of a larger 
study.   
 
Who is organising and funding the research? 
 
This study is organised and funded by the University of Birmingham. 
 
Who has reviewed the study? 
 
If approved this section will read: 
The study has been independently reviewed and approved by (specific area meeting) 
Research Ethics Committee and Birmingham and Solihull Mental Health Foundation Trust 
Research and Development. 
 
Further information about the study 
 
If you would like to ask any questions about the study, please telephone Dionne Harleston on 
the contact details below.  If she is not there when you call, please leave a message and she 
will call you back as soon as possible. 
 
You will be given a copy of the consent form and information sheet signed by the researcher. 
 




Dionne Harleston         
School of Psychology      
University of Birmingham,      
Edgbaston,       
Birmingham,  B15 2TT 
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Appendix 3: Participant Consent Form 











Study number: 12/WM/0171 




Title of Project: Testing a Brief intervention on a Mental Health In-Patient Unit. 
            Name of Researcher:           
                                                                                                             Please initial box 
 
1. I confirm that I have read and understood the participant  
Information sheet dated 24/05/2012 for the above study.  I have  
had the opportunity to consider the information, ask questions 
and have had these answered satisfactorily. 
 
2. I understand that my participation is voluntary and that I am free 
to withdraw at any time without giving any reason, and without  
my medical care or legal rights being affected.  
 
 
3. I agree to the interview being audio-recorded.  The audio recording 
  Will be erased when the study is completed. 
 
4. I consent to being contacted one month after my participation 
            ends to arrange a follow-up meeting.  
 
5.        I understand that relevant sections of my medical notes and data          
           collected during the study may be looked at by individuals  
           from the University of Birmingham, from regulatory authorities or  
           from the NHS Trust, where it is relevant to my taking part in this   
           research. I give permission for these individuals to have access to  
           my records. 
 
6. I agree to my GP being informed of my participation in the study.    
  
 





____________________ ___________            ______________________ 
Name of Participant Date            Signature 
 
 
__________________ __________  ____________________ 
Name of Person                Date                        Signature 
taking consent 









Dionne Harleston  
School of Psychology   
University of Birmingham,  
Edgbaston,     
Birmingham, 
B15 2TT     
   
 
Tel: 0121 XX XXXX     





Appendix 4: GP/HP Letter 
                                                                                                       




                                                                                                                                         Date: 
Dear (Name of GP or other health professional) 
 
 
Re: Testing a Brief intervention on a Mental Health In-Patient Unit. 
 
I am writing to inform you that your patient (name; DOB) has consented to take part in our study 
testing a brief intervention with service users on in-patient wards who misuse substances (drugs and 
alcohol). They have consented to me contacting you.  The aim of this study is to; (i) test a  “short 
burst” brief intervention with in-patients with co-occurring mental health diagnosis and substance 
misuse, via a series of case studies; (ii) explore occurring process variables (subjective measures of 
confidence and importance); and (iii) evaluate outcome variables (motivation to change, insight and 
engagement with services).  The study may hopefully help in the long term to improve services for 
people with mental health difficulties and co-existing substance misuse. 
 
Your patient has been asked to undertake: 
 
1. A pre intervention assessment consisting of administered measures on engagement, motivation 
to change and substance use. Socio-demographic information will also be sought. 
2. 4x brief motivational intervention sessions (with subjective measures of experiences) over two 
weeks.  Each will take 15-30 minutes.  
3. A post intervention assessment repeating measures on engagement, motivation to change and 
substance use. 
 
Patients have also been asked to consent to the researcher contacting them to undertake a one hour 
follow-up one month after the intervention.  
 
The research will be undertaken on the unit.  At the point of discharge research may be completed in 
the community.  Any travel expenses participants may have incurred will be reimbursed. 
 
All information obtained will be treated in the strictest confidence and held anonymously in a secure 
office at the University of Birmingham.  
 
Participants will be reminded that they are free at any time not to answer questions they do not want to, 
or to withdraw from the study completely. If a patient becomes distressed during or after the 
intervention or interview they will be advised to discuss this with their nurse, consultant psychiatrist or 
other appropriate staff member. It is possible s/he may wish to discuss issues arising from their 
participation with you as well, which is why I felt it was important to write to you. 
 







Trainee Clinical Psychologist 
(Under the supervision of Consultant Clinical Psychologists, Alex Copello and Hermine Graham)
Dionne Harleston   
School of Psychology   
University of Birmingham,   
Edgbaston,     
Birmingham, 
B15 2TT     
   
 
Tel: 0121 XX XXXX     





Appendix 5: Maudsley Addiction Profile (MAP) substance misuse section 
135 
 























































IS – (present) 
 
Please read the following statements carefully and then tick the box which 




 Agree Disagree Unsure 
1. Some of the symptoms were made 
by my mind 
 
   
2. I am mentally well 
 
 
   
3. I do not need medication 
 
 
   
4. My stay in hospital was necessary 
    
5. The doctor is right in prescribing 
medication for me 
 
   
6. I do not need to be seen by a doctor 
or psychiatrist 
 
   
7. If someone said I had a nervous or 
mental illness then they would be 
right 
   
8. None of the unusual things I 
experienced are due to an illness 
 










       Appendix 9: Severity of Dependence Scale (SDS) 
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Appendix 11 :Intervention Summary 
 
 
         
Intervention Summary 
Testing a Brief intervention on a Mental Health In-Patient Unit. 
 
 
Motivational Brief Intervention  
 
The motivational style brief intervention will be provided in the context of TAU and based 
on a treatment manual. 
 
With the suport of ward staff researchers will aim to build good collaborative relationships 
with participants in order to aid the intervention.   
 
The intervention will seek to encourage participants to engage in talking about their 
substance use and its impact on their mental health, the fundamental first step in the 
process of promoting a readiness and willingness to change problematic drug/alcohol use.  
The aim at this stage will be two-fold, first, increase awareness of the advantages of 
continued substance misuse and the disdvantages of continued substance misuse, and 
second, thereby create cognitive dissonance.  
 
The next stage of the intervention will encourage participants to contemplate change and 
make a change plan.  
 
The structure of the intervention will attempt to map itself onto the stage of recovery in 
acute psychosis in a targetted manner.  It will target the initial window of contemplation 
during the admission and then be timed to coincide with just prior to when "sealing over" 




 Engagement/Rapport Building: putting substance use on the agenda using 
advantages/disadvantages analysis. 
 
 Awareness of impact of substance use: provision of psychoeducational material 
(nature of psychosis and role of substances and medication) & provide personalised 
feedback from assessment. Encouraged to access websites offering information 
about alcohol (‘Down your Drink’) and drugs (‘Talk to Frank’). 
 





 Make a change plan:  look at importance and confidence in changing, realistic 




Clients will receive four individual sessions (15-30 minutes max. each) delivered over a 2-
week period. 
 
Researchers will be trained and supervised in the delivery of the intervention by the 
supervisors (Hermine Graham and Alex Copello). The standard to which researchers 
deliver the intervention will be regularly monitored and assessed for fidelity and adherence 














































Appendix 12: Interview Guide 
 
 
         
 
Interview Guide for brief semi –structured interview 
Testing a Brief intervention on a Mental Health In-Patient Unit. 
  
Questions Possible Probes 
 
Q1. What was your experience of 
taking part in this intervention? 
How was talking to the researcher?  
Engaging with someone?  Talking 
about your difficulties? (Mental 
health, Substance use, treatment etc.) 
Q2. What was helpful about taking 
part in this intervention? 
 
 
Any benefits?  What was good?   
Why? 
Q3. What was unhelpful about taking 
part in the intervention? 
 
 
Negatives?  Anything important to 
you that was missed?  Parts that were 
not good?  Why? 
Q4.  Do you have any suggestions for 




How may it have been more helpful to 
you?  Your idea of support for your 
















Appendix 13: Demographic information 
 
         
Demographic front sheet 
Testing a Brief intervention on a Mental Health In-Patient Unit. 
  
Sex Male______ female______ 
Ethnicity White British______ 








Other Asian (Please specify) ______ 
Chinese______ 
Other (Please Specify) ______ 











Employment Full time employed______ 








Accommodation Rent ______ 
Own______ 
Staying with family members______ 







































Appendix 14: Clients not receiving intervention 
Pre-Intervention characteristics                       
Personal details 
HL, EB, NJ, MR were three white British males ranging in age from 21 to 49 years old and a 
32 year black British female (NJ). All but one of the non-intervention cases were unemployed 
(HL was employed prior to admission) and all either rented or lived with family.  
Substance use history 
HL’s main drug of choice was cannabis, EB and MR mainly used alcohol and NJ’s was a poly 
drug user of crack cocaine and heroin.  All non-intervention cases had first tried their drug of 
choice before the age of 16 except NJ who was 18 when she first tried crack cocaine.  
Mental health history 
HL, NJ and MR all had a diagnosis of Schizophrenia (HL additionally with ‘mental and 
behavioural disorders due to use of cannabinoids; harmful use’). HL was experiencing his first 
inpatient admission.  NJ and MR had experienced previous inpatient admissions. EB had a 
diagnosis of Bipolar Affective Disorder (BPAD). 
Routine Care  
All non-intervention cases were on the same wards as intervention cases and subject to the 
TAU already described for the intervention cases.   
Orientation toward change 
HL and MR had not been offered support for their substance misuse difficulties in the six 
months prior to baseline assessment.  EB had no treatment either but had been engaged by his 
CPN and offered a leaflet but was “not interested”.  In contrast NJ had been engaged with a 
citywide drug service for the last eight years and up until the point of admission.  Motivation 
to change varied by the non-intervention cases.  In addition to self-report at interview, case 
notes, clinician reporting and SATs scores for HL and NJ were consistent with a 
contemplation stage of change. Information for EB and MR was consistent with a pre-
contemplation stage of change.
149 
 












Insight SDS SATS AUDIT 
HL RCI=-0.89, 
p=0.372 
RCI = -3.02; 
p = 0.003* 
RCI = -













EB RCI= -0.30, 
p=0.76 
RCI = -0.67; 
p = 0.502 
RCI = 












NJ RCI = -0.59; 






























*P<0.01    **P<0.05 
